Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
No disease named “lymphatic malformation 9” in GeDiPNet.
Did you mean:
4,070 of 5,762 diseases
(71%) fall into one of 426 clusters.
The remaining 1,692 don't share enough genes with a group of 5+ diseases to form one ‐
see Shared-Gene Disease Pairs for their pairwise links.
| Cluster ⇵ | # Diseases ⇵ | Sample members | Top biological theme ⇵ |
|---|---|---|---|
| Cluster 1 | 81 | Acute disseminated encephalomyelitis, Anti-neutrophil antibody associated vasculitis, Antiphospholipid syndrome, Apolipoprotein b hypobetalipoproteinemia, Arthritis and 76 more |
Leishmaniasis
Pathway · q=2.42e-18
|
| Cluster 2 | 78 | 3-methylcrotonyl-coa carboxylase deficiency, Alopecia-neurological defects-endocrinopathy syndrome, Alzheimer disease, Anxiety disorder, Atrial fibrillation and 73 more |
positive regulation of transcription by RNA polymerase II
GO · q=7.81e-22
|
| Cluster 3 | 46 | 5-oxoprolinase deficiency, Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia, Atrial flutter, Atrial tachyarrhythmia, infra-hisian cardiac conduction disease and 41 more |
regulation of heart rate by cardiac conduction
GO · q=1.50e-44
|
| Cluster 4 | 40 | Acantholytic blistering of oral and laryngeal mucosa, amyotrophic lateral sclerosis type 18, Anus neoplasms, Borderline personality disorder, Breast neoplasms and 35 more |
Pathways in cancer
Pathway · q=5.38e-53
|
| Cluster 5 | 38 | 1q44 microdeletion syndrome, Al kaissi syndrome, Al-raqad syndrome, aspartylglucosaminuria, basilicata-akhtar syndrome and 33 more |
nervous system development
GO · q=5.04e-39
|
| Cluster 6 | 36 | Acyl-coa binding domain containing protein 5 deficiency, Alzahrani-kuwahara syndrome, autosomal recessive optic atrophy, OPA7 type, BBS5-related ciliopathy, CERKL-related retinopathy and 31 more |
visual perception
GO · q=8.66e-124
|
| Cluster 7 | 35 | ALG6-congenital disorder of glycosylation 1C, Aplasia of the vermis, Arima syndrome, Bardet-biedl syndrome, bardet-biedl syndrome 16 and 30 more |
cilium assembly
GO · q=5.44e-85
|
| Cluster 8 | 34 | Bone remodeling disease, Ciliary dyskinesia, ciliary dyskinesia, primary, 36, x-linked, ciliary dyskinesia, primary, 42, ciliary dyskinesia, primary, 43 and 29 more |
cilium movement
GO · q=1.03e-38
|
| Cluster 9 | 31 | Acrofacial dysostosis, Bowen’s disease, Cecal neoplasms, Cervicitis, Craniofaciocardiohepatic syndrome and 26 more |
Pathways in cancer
Pathway · q=9.27e-20
|
| Cluster 10 | 28 | autosomal dominant combined immunodeficiency due to ERBIN deficiency, Combined immunodeficiency disease, combined immunodeficiency due to CD3gamma deficiency, combined immunodeficiency due to GINS1 deficiency, combined immunodeficiency due to LRBA deficiency and 23 more |
T cell activation
GO · q=1.68e-23
|
| Cluster 11 | 26 | autosomal recessive limb-girdle muscular dystrophy, Axonal neuropathy with neuromyotonia, Bjornstad syndrome, Congenital muscular dystrophy, Congenital muscular dystrophy due to dystroglycanopathy and 21 more |
Cytoskeleton in muscle cells
Pathway · q=3.00e-28
|
| Cluster 12 | 24 | Aneurysm, Aortic aneurysm, Bone marrow failure and diabetes mellitus syndrome, Boudin-mortier syndrome, cardiomyopathy, dilated, 2j and 19 more |
skeletal system development
GO · q=1.34e-23
|
| Cluster 13 | 23 | Avascular necrosis of femoral head, Beukes hip dysplasia, Chondrosarcoma, COL2A1-related spondyloepiphyseal dysplasia, Collagenopathy and 18 more |
cartilage development involved in endochondral bone morphogenesis
GO · q=1.05e-4
|
| Cluster 14 | 22 | Amyotrophic lateral sclerosis, Charcot-marie-tooth disease, Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2D and 17 more |
Amyotrophic lateral sclerosis
Pathway · q=1.82e-9
|
| Cluster 15 | 22 | ALG1-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation, ALG3-congenital disorder of glycosylation, COG1-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation and 17 more |
N-Glycan biosynthesis
Pathway · q=8.65e-46
|
| Cluster 16 | 22 | Angiocentric glioma, beta-thalassemia HBB/LCRB, Cooleys anemia, Cyanosis, Delta-beta thalassemia and 17 more |
carbon dioxide transport
GO · q=1.43e-8
|
| Cluster 17 | 21 | Androgenetic alopecia, Breast cancer, C3hex olfactory ability, Cancer, Colorectal adenoma and 16 more |
positive regulation of transcription by RNA polymerase II
GO · q=1.43e-19
|
| Cluster 18 | 21 | Adrenocortical carcinoma, B-cell acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia, B-lymphoblastic leukemia/lymphoma, Central nervous system neoplasms and 16 more |
positive regulation of transcription by RNA polymerase II
GO · q=3.75e-9
|
| Cluster 19 | 21 | amyotrophic lateral sclerosis, susceptibility to, 24, BBS10-related ciliopathy, Craniodiaphyseal dysplasia, Developmental delay with or without epilepsy, dilated cardiomyopathy 1V and 16 more |
cilium assembly
GO · q=6.03e-33
|
| Cluster 20 | 20 | 17q23.1q23.2 microdeletion syndrome, Amelia, Arthropathy, Bmp4-related ocular growth disorder, Chromosome 17q23.1-q23.2 duplication syndrome and 15 more |
embryonic hindlimb morphogenesis
GO · q=2.06e-6
|
| Cluster 21 | 20 | Allergic contact dermatitis, Atopic dermatitis, Autoimmune hepatitis, Autoinflammation with episodic fever and immune dysregulation, Behcet disease and 15 more |
immune response
GO · q=5.90e-53
|
| Cluster 22 | 19 | Cleft palate and bilateral cleft lip, Congenital cardiomyopathy, Developmental delay, Developmental delay with hypotonia and impaired language, Developmental delay with variable neurological abnormalities and 14 more |
Prion disease
Pathway · q=3.41e-12
|
| Cluster 23 | 19 | Aarskog-scott syndrome, x-linked, Acro-dermo-ungual-lacrimal-tooth syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate, BBS9-related ciliopathy, Bladder exstrophy and 14 more |
protein localization to CENP-A containing chromatin
GO · q=8.15e-6
|
| Cluster 24 | 19 | Benign prostatic hyperplasia, Budd-chiari syndrome, Cerebral venous sinus thrombosis, Cervical polyp, Congenital factor v deficiency and 14 more |
cardiac muscle cell differentiation
GO · q=5.49e-4
|
| Cluster 25 | 19 | Acromelic frontonasal dysostosis, Basal cell carcinoma, Chromosome 20q11-q12 deletion syndrome, Congenital posterior urethral valves, Cutaneous squamous cell carcinoma and 14 more |
Pathways in cancer
Pathway · q=5.37e-11
|
| Cluster 26 | 19 | Auditory neuropathy, autosomal dominant nonsyndromic hearing loss, autosomal recessive nonsyndromic hearing loss 102, autosomal recessive nonsyndromic hearing loss 63, Cone rod dystrophy and hearing loss and 14 more |
sensory perception of sound
GO · q=3.61e-96
|
| Cluster 27 | 19 | Camos syndrome, Congenital nephrotic syndrome, Focal glomerulosclerosis, Focal segmental glomerulosclerosis, focal segmental glomerulosclerosis and neurodevelopmental syndrome and 14 more |
AGE-RAGE signaling pathway in diabetic complications
Pathway · q=2.35e-10
|
| Cluster 28 | 19 | Autoimmune lymphoproliferative disorder, autoimmune lymphoproliferative syndrome type 2A, bamforth-lazarus syndrome, Bladder cancer, ciliary dyskinesia, primary, 39 and 14 more |
Apoptosis
Pathway · q=1.28e-9
|
| Cluster 29 | 18 | Blood coagulation disorder, Cerebral hemorrhage, Disseminated intravascular coagulation, Fetal erythroblastosis, Hemophilia a and 13 more |
blood coagulation
GO · q=1.92e-60
|
| Cluster 30 | 18 | Bone dysplasia with increased bone density, Brain tumor-polyposis syndrome, Cenani-lenz syndrome, congenital myasthenic syndrome 17, Desmoid tumor and 13 more |
Pathways in cancer
Pathway · q=7.58e-13
|
| Cluster 31 | 18 | ALG2-congenital disorder of glycosylation, Alstrom syndrome, Ataxia, spastic, autosomal dominant, Congenital myasthenic syndrome, congenital myasthenic syndrome 10 and 13 more |
synaptic transmission, cholinergic
GO · q=6.92e-10
|
| Cluster 32 | 17 | Abetalipoproteinemia, Carotid artery disease, Congenital hyperinsulinism, Diabetic ketoacidosis, Fanconi-bickel syndrome and 12 more |
Maturity onset diabetes of the young
Pathway · q=5.35e-16
|
| Cluster 33 | 17 | Angle closure glaucoma, Avascular necrosis of bone, Chromosome 5q deletion syndrome, congenital muscular dystrophy with intellectual disability and severe epilepsy, hereditary fructose intolerance and 12 more |
response to hypoxia
GO · q=4.10e-9
|
| Cluster 34 | 17 | Advanced sleep phase syndrome, Alpha-mannosidosis, Anencephaly, Aprosencephaly, Cobalamin c disease and 12 more |
Cobalamin transport and metabolism
Pathway · q=6.32e-26
|
| Cluster 35 | 16 | 46, xy disorder of sex development, 46,xx ovotesticular disorder of sex development, 46,xx sex reversal, 46,xy gonadal dysgenesis, 46,xy partial gonadal dysgenesis and 11 more |
positive regulation of male gonad development
GO · q=5.94e-15
|
| Cluster 36 | 16 | amyotrophic lateral sclerosis type 15, Brody myopathy, Cohen syndrome, fanconi anemia complementation group p, GPR161-related medulloblastoma predisposition and 11 more |
pituitary gland development
GO · q=4.02e-8
|
| Cluster 37 | 16 | arrhythmogenic cardiomyopathy with variable ectodermal abnormalities, Blepharoptosis, Cardiofaciocutaneous syndrome, Congenital malformation syndromes associated with short stature, Congenital malrotation of intestine and 11 more |
Ras signaling pathway
Pathway · q=3.48e-14
|
| Cluster 38 | 16 | Anterior polar cataract, Cataract, Cataract-microcornea syndrome, Congenital cataract, Congenital cataract facial dysmorphism neuropathy syndrome and 11 more |
lens development in camera-type eye
GO · q=1.72e-26
|
| Cluster 39 | 16 | Capillary-lymphatic-venous malformation, Charcot-Marie-Tooth disease type 2A1, Charcot-Marie-Tooth disease type 4C, Clapo syndrome, Cloves syndrome and 11 more |
facultative heterochromatin formation
GO · q=2.35e-6
|
| Cluster 40 | 16 | CACNA2D4-related retinopathy, Central areolar choroidal dystrophy, Choroidal dystrophy, Choroidal sclerosis, Choroideremia and 11 more |
visual perception
GO · q=1.08e-16
|
| Cluster 41 | 15 | Cardiac-urogenital syndrome, Chylothorax, ciliary dyskinesia, primary, 38, ciliary dyskinesia, primary, 40, congenital heart disease with heterotaxy syndrome and 10 more |
determination of left/right symmetry
GO · q=3.71e-20
|
| Cluster 42 | 15 | ALG9-associated autosomal dominant polycystic kidney disease, autosomal dominant medullary cystic kidney disease with or without hyperuricemia, Hyperuricemic nephropathy, Juvenile hyperuricemic nephropathy, Malignant hypertension and 10 more |
kidney development
GO · q=1.67e-16
|
| Cluster 43 | 15 | Beta thalassemia, Digenic hemochromatosis, Hemochromatosis, hemochromatosis type 1, hemochromatosis type 2A and 10 more |
multicellular organismal-level iron ion homeostasis
GO · q=2.05e-18
|
| Cluster 44 | 15 | Alport syndrome, Alport syndrome, x-linked, Collagen vi-related myopathy, Diaphragm disease, Diffuse mesangial sclerosis and 10 more |
NCAM1 interactions
Pathway · q=4.54e-9
|
| Cluster 45 | 15 | Acyl-coa dehydrogenase 9 deficiency, Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, Codas syndrome, Combined oxidative phosphorylation deficiency, Cytochrome c oxidase deficiency and 10 more |
Respiratory electron transport
Pathway · q=6.64e-71
|
| Cluster 46 | 15 | Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, colobomatous microphthalmia-rhizomelic dysplasia syndrome, Colobomatous optic disc macular atrophy chorioretinopathy syndrome and 10 more |
camera-type eye development
GO · q=1.64e-20
|
| Cluster 47 | 15 | arrhythmogenic right ventricular dysplasia 5, Congenital small ears, dilated cardiomyopathy 1A, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Emery dreifuss muscular dystrophy and 10 more |
Cytoskeleton in muscle cells
Pathway · q=2.70e-5
|
| Cluster 48 | 15 | Arthrogryposis with perthes disease and gaze palsy, autosomal dominant centronuclear myopathy, Congenital deformity of clavicle, Congenital deformity of elbow, Congenital deformity of forearm and 10 more |
myelination in peripheral nervous system
GO · q=1.38e-4
|
| Cluster 49 | 14 | Catifa syndrome, Cleft lip, Cleft lip and palate, Cleft palate, Complete unilateral cleft lip and 9 more |
odontogenesis of dentin-containing tooth
GO · q=7.27e-15
|
| Cluster 50 | 14 | Ankylosis, Antley-bixler syndrome, Beare-stevenson cutis gyrata syndrome, Biliary tract neoplasms, Cardiofacial dysplasia and 9 more |
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
GO · q=3.38e-4
|
| Cluster 51 | 14 | Antisocial personality disorder, Brunner syndrome, Colchicine resistance, Conduct disorder, Congenital dyserythropoietic anemia and 9 more |
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
GO · q=3.53e-5
|
| Cluster 52 | 13 | 11p partial monosomy syndrome, Ambiguous genitalia, Aniridia, Autoimmune nervous system disorder, Congenital aniridia and 8 more |
anatomical structure morphogenesis
GO · q=1.44e-8
|
| Cluster 53 | 13 | Cardiac valvular dysplasia, Conductive hearing loss, Congenital idiopathic intestinal pseudoobstruction, Congenital short bowel syndrome, Cystic fibrosis-related diabetes and 8 more |
positive regulation of gene expression
GO · q=1.63e-3
|
| Cluster 54 | 13 | B3GALT6-congenital disorder of glycosylation, Carpal tunnel syndrome, Congenital cartilage disorder, Copper metabolism disorder, Hoxha-aliu syndrome and 8 more |
ECM proteoglycans
Pathway · q=4.81e-10
|
| Cluster 55 | 13 | Aortic dissection, Aortic rupture, Arterial tortuosity syndrome, Atypical femoral fracture, Cutaneous polyarteritis nodosa and 8 more |
elastic fiber assembly
GO · q=1.48e-7
|
| Cluster 56 | 13 | Biliary tract cancer, Cardiofacio-neurodevelopmental syndrome, Cervical cancer, Endometrial cancer, Endometrial neoplasms and 8 more |
cell division
GO · q=8.71e-17
|
| Cluster 57 | 13 | Acetyl-coa carboxylase deficiency, Atherosclerosis, Cerebrovascular disorder, Erectile dysfunction, Heart disease and 8 more |
positive regulation of gene expression
GO · q=2.64e-21
|
| Cluster 58 | 13 | Anorexia nervosa, cardiomyopathy, dilated, 2f, Charcot-Marie-Tooth disease, axonal, type 2FF, Congenital thrombotic disease, Early-onset distal myopathy and 8 more |
chemical synaptic transmission
GO · q=6.16e-6
|
| Cluster 59 | 13 | Acromesomelic dysplasia, Arthrogryposis-renal dysfunction-cholestasis syndrome, Congenital pectus carinatum, Congenital scoliosis, Coronary artery dissection and 8 more |
Defective B3GALTL causes Peters-plus syndrome (PpS)
Pathway · q=2.33e-7
|
| Cluster 60 | 13 | Adenomatous polyposis, Colorectal adenomatous polyposis, Congenital kidney anomaly, Focal cortical dysplasia, Folic acid deficiency and 8 more |
Energy dependent regulation of mTOR by LKB1-AMPK
Pathway · q=8.20e-6
|
| Cluster 61 | 13 | Congenital isolated acth deficiency, Cri-du-chat syndrome, Ductal carcinoma of breast, Duodenitis, dyskeratosis congenita, autosomal dominant 2 and 8 more |
Gastric cancer
Pathway · q=7.87e-7
|
| Cluster 62 | 13 | Anastomosing haemangioma, Aplasia cutis congenita with epibulbar dermoids, Arteriovenous malformations, Capillary malformation, Capillary malformation-arteriovenous malformation and 8 more |
GnRH secretion
Pathway · q=2.40e-6
|
| Cluster 63 | 13 | Berardinelli-seip congenital lipodystrophy, Carotid intima-media thickness, Central nervous system malformation, Congenital generalized lipodystrophy, Epithelial ovarian carcinoma and 8 more |
Apoptosis
Pathway · q=5.87e-5
|
| Cluster 64 | 13 | Aphasia, Cardiac tamponade, Commisural aphasia, cutis laxa, autosomal dominant 1, Dejerine-lichtheim phenomenon and 8 more |
positive regulation of chronic inflammatory response to antigenic stimulus
GO · q=4.89e-5
|
| Cluster 65 | 13 | Alpha thalassemia, Chloracne, erythrocytosis, familial, 7, HBA1-related alpha thalassemia spectrum, HBA2-related alpha thalassemia spectrum and 8 more |
carbon dioxide transport
GO · q=2.12e-8
|
| Cluster 66 | 13 | Amino acid metabolism disorder, Argininosuccinic aciduria, Citrin deficiency, Citrullinemia, Cystathioninuria and 8 more |
urea cycle
GO · q=4.03e-14
|
| Cluster 67 | 13 | Body weight, Diabetes mellitus, Diabetic eye disease, Diabetic nephropathy type 2, Diabetic neuropathy and 8 more |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
GO · q=2.83e-11
|
| Cluster 68 | 13 | Anaplasia, Bladder disease, Childhood-onset glut1 deficiency syndrome 2, Choreoathetosis, Chromosome 17q23.1-q23.2 deletion syndrome and 8 more |
Central carbon metabolism in cancer
Pathway · q=7.88e-7
|
| Cluster 69 | 13 | anemia, nonspherocytic hemolytic, due to G6PD deficiency, Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome, Congenital nonspherocytic hemolytic anemia and 8 more |
Cross-presentation of particulate exogenous antigens (phagosomes)
Pathway · q=4.50e-9
|
| Cluster 70 | 13 | Atrioventricular septal defect, Brain abnormalities developmental delay facial dysmorphism intellectual disability syndrome, Chromosome 8p23.1 monosomy, Congenital pulmonary valve atresia, GATA4-related congenital heart disease with or without pancreatic hypoplasia or diabetes and 8 more |
atrioventricular canal development
GO · q=1.25e-5
|
| Cluster 71 | 12 | Auditory perceptual disorder, Congenital hereditary endothelial dystrophy, Congenital stromal corneal dystrophy, Corneal dystrophy, Corneal endothelial dystrophy and 7 more |
MET activates PTK2 signaling
Pathway · q=7.72e-6
|
| Cluster 72 | 12 | Alcoholic hepatitis, ALG11-congenital disorder of glycosylation, Angina pectoris, Autoimmune uveitis, Cachexia and 7 more |
Interleukin-4 and Interleukin-13 signaling
Pathway · q=1.08e-12
|
| Cluster 73 | 12 | 17q11 microdeletion syndrome, 17q11.2 microduplication syndrome, Cafe-au-lait spots, Cervical lymphadenopathy, Embryonal nuclear cataract and 7 more |
regulation of cell population proliferation
GO · q=4.92e-6
|
| Cluster 74 | 12 | Ankylosing spondylitis, Autoinflammatory disease, systemic, with vasculitis, Benign flecked retina, Crohn disease, Ehrlich tumor carcinoma and 7 more |
immune response
GO · q=4.61e-35
|
| Cluster 75 | 12 | 3m syndrome, autosomal recessive cerebellar ataxia, Cayman type cerebellar ataxia, Cerebellar ataxia, Spastic ataxia and 7 more |
Spinocerebellar ataxia
Pathway · q=8.59e-13
|
| Cluster 76 | 12 | A4GALT-congenital disorder of glycosylation, Caffey disease, Cholangitis, COL1A1-related Ehlers-Danlos syndrome, Combined osteogenesis imperfecta and ehlers-danlos syndrome and 7 more |
collagen fibril organization
GO · q=2.20e-5
|
| Cluster 77 | 12 | Anhydramnios, autosomal recessive polycystic kidney disease, Biliary-renal-neuro-skeletal syndrome, Caroli disease, Congenital hypoplasia of aortic arch and 7 more |
kidney development
GO · q=8.14e-11
|
| Cluster 78 | 12 | Accessory skin tag, autosomal recessive cutis laxa type 2B, autosomal recessive cutis laxa type 2C, autosomal recessive cutis laxa type 2D, Benign familial pemphigus and 7 more |
elastic fiber assembly
GO · q=8.29e-10
|
| Cluster 79 | 12 | Aromatic l-amino-acid decarboxylase deficiency, Carcinoid syndrome, Carney complex, Carney-stratakis syndrome, Cowden disease and 7 more |
mitochondrial electron transport, succinate to ubiquinone
GO · q=1.55e-11
|
| Cluster 80 | 12 | Amish brittle hair brain syndrome, Cerebrooculofacioskeletal syndrome, Trichorrhexis nodosa syndrome, Trichothiodystrophy, Xeroderma pigmentosum and 7 more |
Nucleotide excision repair
Pathway · q=2.96e-17
|
| Cluster 81 | 12 | Carotid artery stenosis, Congenital plasminogen activator inhibitor deficiency type 1, Coronary restenosis, Fabry disease, homocystinuria due to methylene tetrahydrofolate reductase deficiency and 7 more |
Interleukin-4 and Interleukin-13 signaling
Pathway · q=1.37e-6
|
| Cluster 82 | 12 | Anterior cruciate ligament injury, Arginase deficiency, Congenital hereditary facial paralysis with variable hearing loss syndrome, Constipation, Eye pain and 7 more |
positive regulation of chemokine production
GO · q=5.48e-5
|
| Cluster 83 | 12 | Aplastic anemia, Dyskeratosis congenita, dyskeratosis congenita and related telomere biology disorder, dyskeratosis congenita, autosomal recessive 2, dyskeratosis congenita, autosomal recessive 3 and 7 more |
Telomere Extension By Telomerase
Pathway · q=3.40e-17
|
| Cluster 84 | 12 | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, Congenital hypothyroidism, Congenital hypothyroidism due to absence of thyroid gland, Congenital hypothyroidism without goiter, Congenital thyroid atrophy and 7 more |
Thyroid hormone synthesis
Pathway · q=2.32e-12
|
| Cluster 85 | 12 | Asymmetric septal hypertrophy, Biventricular noncompaction cardiomyopathy, Camptocormia, Coronary stenosis, dilated cardiomyopathy 1S and 7 more |
cardiac muscle contraction
GO · q=1.45e-8
|
| Cluster 86 | 12 | Ataxia with polyneuropathy, Deafness with congenital onychodystrophy, Deafness-onychodystrophy syndrome, Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome, Digitrenocerebral syndrome and 7 more |
peroxisome fission
GO · q=9.38e-4
|
| Cluster 87 | 12 | Ataxia-hypogonadism-choroidal dystrophy syndrome, Beta-sarcoglycanopathy, Boucher-neuhauser syndrome, Brainstem atrophy, Cerebellar ataxia and hypogonadotropic hypogonadism and 7 more |
N-glycan processing to lysosome
GO · q=1.82e-5
|
| Cluster 88 | 12 | Autoinflammation, panniculitis, and dermatosis syndrome, Bilateral microphthalmos, Calcium metabolism disorders, Calcium pyrophosphate deposition, Chondrocalcinosis and 7 more |
Gap junction assembly
Pathway · q=2.35e-4
|
| Cluster 89 | 12 | Cerebral embolism, Hypercalcemia, Hypercalciuria, Idiopathic infantile hypercalcemia, Infertility and 7 more |
Parathyroid hormone synthesis, secretion and action
Pathway · q=8.17e-8
|
| Cluster 90 | 11 | 11p11.2 deletion syndrome, combined immunodeficiency due to ZAP70 deficiency, craniosynostosis 2, Exostoses, exostoses, multiple, type 2 and 6 more |
fluid transport
GO · q=7.47e-4
|
| Cluster 91 | 11 | 15q13.3 microdeletion syndrome, Auditory system disease, autosomal dominant cerebellar ataxia, Caudal regression syndrome, Congenital exomphalos and 6 more |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis
GO · q=2.35e-4
|
| Cluster 92 | 11 | 22q11 deletion syndrome, ciliary dyskinesia, primary, 46, Congenital heart malformation, Gastrointestinal stromal tumor, Holoprosencephaly and 6 more |
smoothened signaling pathway
GO · q=5.16e-40
|
| Cluster 93 | 11 | Bulimia, Childhood myocerebrohepatopathy spectrum, Dysphonia, fanconi anemia complementation group i, Intermittent explosive disorder and 6 more |
mitochondrial DNA replication
GO · q=1.86e-8
|
| Cluster 94 | 11 | Biotinidase deficiency, Brachydactyly, Brachydactyly-syndactyly syndrome, Brachymesophalangy, Cryptorchidism and 6 more |
chondrocyte differentiation
GO · q=8.15e-8
|
| Cluster 95 | 11 | Hyperthermia, Hypochromic anemia, Hypochromic microcytic anemia, Hypochromic sideroblastic anemia, IRIDA syndrome and 6 more |
intracellular iron ion homeostasis
GO · q=3.84e-14
|
| Cluster 96 | 11 | Abcd syndrome, Central precocious puberty, Craniofacial deafness hand syndrome, Intestinal aganglionosis, Kleins syndrome and 6 more |
melanocyte differentiation
GO · q=2.02e-6
|
| Cluster 97 | 11 | Alexander disease, Combined psap deficiency, Combined saposin deficiency, Gaucher disease, Gaucher disease due to saposin C deficiency and 6 more |
sensory perception of light stimulus
GO · q=1.98e-12
|
| Cluster 98 | 11 | Angiofollicular ganglionic hyperplasia, Angiolymphoid hyperplasia, Castleman disease, Cerebellar vermis atrophy, Cerebral arteriovenous malformations and 6 more |
Endocrine resistance
Pathway · q=4.33e-6
|
| Cluster 99 | 11 | Developmental delay with dysmorphic facies and brain anomalies, Hypomyelinating leukodystrophy, hypomyelinating leukodystrophy 5, hypomyelinating leukodystrophy 9, Leukodystrophy and 6 more |
Cytosolic tRNA aminoacylation
Pathway · q=4.47e-8
|
| Cluster 100 | 11 | Aminoaciduria, Developmental delay with immunodeficiency syndrome, Endocrine system disease, Hepatic insufficiency, Hepatomegaly and 6 more |
Pathways in cancer
Pathway · q=1.05e-13
|
| Cluster 101 | 11 | Cerebellar-facial-dental syndrome, Congenital microcephaly, Diffuse cerebral and cerebellar atrophy–intractable seizures–progressive microcephaly syndrome, microcephalic osteodysplastic primordial dwarfism type II, Microcephaly and 6 more |
cell division
GO · q=2.62e-15
|
| Cluster 102 | 11 | Bradyopsia, Chiari-frommel syndrome, Delirium, Disruptive impulse-control and conduct disorder, Dyskinesia, drug-induced and 6 more |
Hormone signaling
Pathway · q=1.46e-14
|
| Cluster 103 | 11 | amyotrophic lateral sclerosis type 6, ciliary dyskinesia, primary, 54, Frontotemporal dementia, frontotemporal dementia and/or amyotrophic lateral sclerosis, frontotemporal dementia and/or amyotrophic lateral sclerosis 1 and 6 more |
Amyotrophic lateral sclerosis
Pathway · q=3.00e-11
|
| Cluster 104 | 11 | autosomal systemic lupus erythematosus type 16, Crest syndrome, Dermatomyositis, Diffuse cutaneous systemic sclerosis, immunodeficiency 25 and 6 more |
Inflammatory bowel disease
Pathway · q=3.81e-17
|
| Cluster 105 | 11 | Cerebral microangiopathy, COL4A1-related disorder, Colpocephaly, Congenital hypogonadotropic hypogonadism, Dementia in huntington’s disease and 6 more |
telencephalon regionalization
GO · q=1.52e-3
|
| Cluster 106 | 11 | Anemia, x-linked, Congenital erythropoietic porphyria, Cutaneous porphyria, Dyserythropoietic anemia with abnormal platelets and neutropenia, Dyserythropoietic anemia with thrombocytopenia and 6 more |
heme B biosynthetic process
GO · q=7.41e-23
|
| Cluster 107 | 11 | Bombay phenotype, Deficiency anemia, Imerslund-grasbeck syndrome, Megaloblastic anemia, methylmalonic acidemia due to transcobalamin receptor defect and 6 more |
Cobalamin (Cbl, vitamin B12) transport and metabolism
Pathway · q=2.56e-13
|
| Cluster 108 | 11 | Atypical hemolytic uremic syndrome, Central serous retinopathy, Choroid diseases, Doyne honeycomb retinal dystrophy, Factor h deficiency and 6 more |
regulation of complement-dependent cytotoxicity
GO · q=1.15e-3
|
| Cluster 109 | 11 | ciliary dyskinesia, primary, 47, and lissencephaly, Constitutional mismatch repair deficiency, Cystic leukoencephalopathy, Fanconi anemia complementation group U, Hereditary breast cancer and 6 more |
DNA damage response
GO · q=2.05e-27
|
| Cluster 110 | 10 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, ciliopathy-IFT74, Congenital brain malformation, Congenital hypoplasia of part of brain, Hydranencephaly and 5 more |
neuron migration
GO · q=9.80e-13
|
| Cluster 111 | 10 | Angelman syndrome, Bruxism, CDKL5 disorder, Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia, Congenital retinal aneurysm and 5 more |
synaptic transmission, GABAergic
GO · q=3.19e-5
|
| Cluster 112 | 10 | Chromosome 15q deletion syndrome, Congenital heart defects, Congenital heart disease, Conotruncal cardiac defect, Craniofacial abnormalities and 5 more |
heart development
GO · q=3.33e-47
|
| Cluster 113 | 10 | 22q13 monosomy syndrome, 22q13.3 deletion syndrome, Dopa-responsive dystonia, Dystonia, dopa-responsive, with or without hyperphenylalaninemia, GTP cyclohydrolase I deficiency and 5 more |
positive regulation of nitric-oxide synthase activity
GO · q=1.20e-4
|
| Cluster 114 | 10 | Avoidant restrictive food intake disorder, Bile duct calculus, Cavitary optic disc anomalies, Cavitary optic disk anomaly, Delayed sleep phase syndrome and 5 more |
axonogenesis involved in innervation
GO · q=4.72e-5
|
| Cluster 115 | 10 | Congenitally uncorrected transposition of the great arteries, Discordant ventriculoarterial connection, Double outlet right ventricle, Down syndrome, immunodeficiency 114, folate-responsive and 5 more |
heart development
GO · q=6.72e-5
|
| Cluster 116 | 10 | Apert syndrome, Cataract-intellectual disability-hypogonadism syndrome, Congenital malformation syndromes predominantly affecting facial appearance, Cryptophthalmos syndrome, Cyclocephaly and 5 more |
branching involved in salivary gland morphogenesis
GO · q=1.12e-4
|
| Cluster 117 | 10 | Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Desbuquois syndrome, ehlers-danlos syndrome, spondylodysplastic type, 1, Larsen syndrome and 5 more |
skeletal system development
GO · q=4.50e-57
|
| Cluster 118 | 10 | Brain injuries, Brain ischemia, Colitis, Developmental delay with overweight and facial dysmorphism, inflammatory skin and bowel disease, neonatal, 1 and 5 more |
inflammatory response
GO · q=6.03e-33
|
| Cluster 119 | 10 | Hyperekplexia epilepsy syndrome, Intellectual developmental disorder, x-linked, intellectual disability, X-linked 106, syndromic X-linked intellectual disability Nascimento type, syndromic X-linked intellectual disability Raymond type and 5 more |
modulation of chemical synaptic transmission
GO · q=3.42e-4
|
| Cluster 120 | 10 | Absence of fingerprints-congenital milia syndrome, Anhidrotic ectodermal dysplasia, Christ-siemens-touraine syndrome, Craniofrontonasal dysplasia, Ectodermal dysplasia and 5 more |
epidermis development
GO · q=5.45e-7
|
| Cluster 121 | 10 | Bronchopulmonary dysplasia, Chronic obstructive pulmonary disease, Cystic fibrosis, Emphysema, Genetic generalized epilepsy and 5 more |
inflammatory response
GO · q=1.31e-23
|
| Cluster 122 | 10 | Amnesia, Bradycardia, Catalepsy, Edema, Hyperalgesia and 5 more |
Neuroactive ligand-receptor interaction
Pathway · q=1.43e-40
|
| Cluster 123 | 10 | Becker muscular dystrophy, Benign congenital myopathy, Clinodactyly, Duchenne muscular dystrophy, Dystrophinopathy and 5 more |
Dilated cardiomyopathy
Pathway · q=2.70e-3
|
| Cluster 124 | 10 | Alpha thalassemia x-linked intellectual disability, Atr-x syndrome, Intellectual developmental disorder hypotonic x-linked, non-syndromic X-linked intellectual disability, Penile disease and 5 more |
response to inositol
GO · q=6.11e-4
|
| Cluster 125 | 10 | Arterial occlusive disease, Asthenozoospermia, Brain edema, Cardiac injury, Cholesterol embolism and 5 more |
response to hypoxia
GO · q=5.31e-5
|
| Cluster 126 | 10 | Anemia, Bisphosphoglycerate mutase deficiency, Charcot-Marie-Tooth disease type 4B2, Coronary vessel anomalies, Erythrocytosis and 5 more |
multicellular organismal-level iron ion homeostasis
GO · q=4.06e-14
|
| Cluster 127 | 10 | Binocular vision disease, Brachycephaly, Coronal craniosynostosis, duane retraction syndrome 2, Extraskeletal myxoid chondrosarcoma and 5 more |
Wnt signaling pathway
GO · q=1.08e-6
|
| Cluster 128 | 10 | Dacryocystitis, Dysthymic disorder, Early-onset obesity-hyperphagia-severe developmental delay syndrome, ectodermal dysplasia and immunodeficiency 2, Exanthema and 5 more |
Alcoholic liver disease
Pathway · q=8.99e-4
|
| Cluster 129 | 10 | Anovulation, autosomal dominant osteopetrosis 2, autosomal recessive osteopetrosis 4, autosomal recessive osteopetrosis 5, autosomal recessive osteopetrosis 8 and 5 more |
osteoclast differentiation
GO · q=2.46e-9
|
| Cluster 130 | 10 | arterial calcification, generalized, of infancy, 1, Cole disease, Coronary medial sclerosis of infancy, Crystal arthropathy, Desbuquois dysplasia and 5 more |
proteoglycan biosynthetic process
GO · q=4.26e-7
|
| Cluster 131 | 10 | Atrial standstill, Cardiac rhythm disease, dilated cardiomyopathy 1E, Ectopic rhythm, Hypercapnia and 5 more |
regulation of heart rate by cardiac conduction
GO · q=4.07e-8
|
| Cluster 132 | 10 | Autoinflammation, immune dysregulation, and eosinophilia, BARD1-related cancer predisposition, BRCA1-related cancer predisposition, Breast implant-associated anaplastic large cell lymphoma, Fanconi anemia and 5 more |
DNA repair
GO · q=2.66e-38
|
| Cluster 133 | 10 | Blast crisis, Bloom syndrome, Chromosome 22q11.2 microdeletion syndrome, Hodgkin disease, Hyper-igm immunodeficiency syndrome and 5 more |
Primary immunodeficiency
Pathway · q=2.40e-8
|
| Cluster 134 | 10 | Bone mineral density quantitative trait locus, Camurati-engelmann syndrome, LRP5-related exudative vitreoretinopathy, Osteopetrosis and infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration and 5 more |
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Pathway · q=4.49e-4
|
| Cluster 135 | 9 | Azoospermia, Congenital alpha-fetoprotein deficiency, Cryptospermia, Male infertility, Male infertility single gene azoospermia and 4 more |
spermatogenesis
GO · q=3.35e-58
|
| Cluster 136 | 9 | 17q12 microdeletion syndrome, Bilateral multicystic dysplastic kidney, Giant cell tumor of tendon sheath, Mayer-rokitansky-kuster-hauser syndrome, Multicystic dysplastic kidney and 4 more |
pronephros development
GO · q=7.11e-9
|
| Cluster 137 | 9 | Mucopolysaccharidosis, mucopolysaccharidosis type 3A, mucopolysaccharidosis type 3B, mucopolysaccharidosis type 3C, mucopolysaccharidosis type 3D and 4 more |
Glycosaminoglycan degradation
Pathway · q=6.04e-24
|
| Cluster 138 | 9 | Adenosine deaminase 2 deficiency, Cardiovascular abnormalities, Deafness-lymphedema-leukemia syndrome, Gata2 deficiency, nephronophthisis 16 and 4 more |
heart development
GO · q=1.70e-7
|
| Cluster 139 | 9 | ciliary dyskinesia, primary, 41, immunodeficiency 104, immunodeficiency, common variable, 12, Intellectual developmental disorder dysmorphic macrocephaly, Nasal disorder and 4 more |
Inflammatory bowel disease
Pathway · q=3.73e-11
|
| Cluster 140 | 9 | ABCA4-related retinopathy, Atrophic retina, Bietti crystalline corneoretinal dystrophy, Cleft palate proliferative retinopathy developmental delay, Diastolic heart failure and 4 more |
Norrin signaling pathway
GO · q=1.40e-4
|
| Cluster 141 | 9 | Autoinflammatory syndrome, familial, behcet-like, developmental and epileptic encephalopathy, 41, Dry eye syndrome, Kawasaki disease, Myositis and 4 more |
Inflammatory bowel disease
Pathway · q=1.13e-18
|
| Cluster 142 | 9 | Autoimmune disease, Autoimmune thyroid disease, Autoinflammation with pulmonary and cutaneous vasculitis, Celiac disease, Common variable immunodeficiency and 4 more |
immune response
GO · q=3.74e-33
|
| Cluster 143 | 9 | Acrocapitofemoral dysplasia, Cernunnos-XLF deficiency, Diencephalic mesencephalic junction dysplasia, Exudative retinopathy, Exudative vitreoretinopathy and 4 more |
embryonic digit morphogenesis
GO · q=1.10e-11
|
| Cluster 144 | 9 | Acrokeratosis verruciformis, adult neuronal ceroid lipofuscinosis, Asymptomatic hyperckemia-myalgia-rhabdomyolysis syndrome, Diabetic cardiomyopathy, Distal anoctaminopathy and 4 more |
lysosome organization
GO · q=1.78e-8
|
| Cluster 145 | 9 | Angiokeratoma, Cavernous malformations of cns, Cerebral cavernous malformation, Congenital cerebral aneurysm, Congenital malformation of cerebral vessels and 4 more |
angiogenesis
GO · q=3.84e-6
|
| Cluster 146 | 9 | Acrocallosal syndrome, Cronkhite-canada syndrome, greig cephalopolysyndactyly syndrome, Hydrolethalus syndrome, Intellectual developmental disorder microcephaly strabismus behaviora and 4 more |
smoothened signaling pathway involved in ventral spinal cord interneuron specification
GO · q=5.63e-5
|
| Cluster 147 | 9 | Conjunctival disease, Disorder of sex development, Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome, Gallbladder neoplasms, Hyperplasia and 4 more |
Pathways in cancer
Pathway · q=8.96e-11
|
| Cluster 148 | 9 | Branchial arch abnormalities syndrome, Branchial cleft anomalies, Burn-mckeown syndrome, Choanal atresia syndrome, Duane-radial ray syndrome and 4 more |
beta-catenin-TCF complex assembly
GO · q=1.22e-2
|
| Cluster 149 | 9 | Bnar syndrome, Craniofaciosynostosis, Encephalocraniocutaneous lipomatosis, Eosinophilic leukemia, Hartsfield-Bixler-Demyer syndrome and 4 more |
Central carbon metabolism in cancer
Pathway · q=8.70e-6
|
| Cluster 150 | 9 | Clonal hematopoiesis, hypotaurinemic retinal degeneration and cardiomyopathy, immunodeficiency, common variable, 14, Leukemia, Myelodysplastic syndrome and 4 more |
Pathways in cancer
Pathway · q=3.07e-27
|
| Cluster 151 | 9 | Asymmetric crying face association, Bor syndrome, Branchiooculofacial syndrome, Branchiootic syndrome, Branchiootorenal syndrome and 4 more |
positive regulation of secondary heart field cardioblast proliferation
GO · q=1.83e-4
|
| Cluster 152 | 9 | Breast fibrocystic disease, Congenital hernia of foramen of bochdalek, Eyelid disease, Inflammatory demyelinating polyneuropathy, Neuropathy and 4 more |
ureteric bud development
GO · q=1.27e-4
|
| Cluster 153 | 9 | Anorexia, Congestive ophthalmopathy, Graft-versus-host disease, Granulomatosis with polyangiitis, Graves ophthalmopathy and 4 more |
immune response
GO · q=3.38e-23
|
| Cluster 154 | 9 | Danon disease, Dimauro disease, Glycogen storage disease, glycogen storage disease due to muscle and heart glycogen synthase deficiency, glycogen storage disease III and 4 more |
glycogen metabolic process
GO · q=2.94e-23
|
| Cluster 155 | 9 | Afibrinogenemia, Congenital afibrinogenemia, Congenital fibrinogen deficiency, Congenital hypofibrinogenemia, Cor pulmonale and 4 more |
hemostasis
GO · q=1.64e-20
|
| Cluster 156 | 9 | Aica-ribosiduria, AIPL1-related retinopathy, Blindness, Congenital blindness, Congenital nystagmus and 4 more |
visual perception
GO · q=5.64e-15
|
| Cluster 157 | 9 | Congenital stationary night blindness, GPR179-related retinopathy, GRM6-related retinopathy, inherited retinal dystrophy, Night blindness, congenital stationary and 4 more |
visual perception
GO · q=7.62e-32
|
| Cluster 158 | 9 | Bone disease, Bone fracture, Childhood hypophosphatasia, Dupuytren contracture, Hypophosphatasia and 4 more |
canonical Wnt signaling pathway
GO · q=7.66e-10
|
| Cluster 159 | 9 | Congenital digestive system anomaly, Congenital hypoplasia of kidney, Medullary carcinoma, Medullary thyroid cancer, multiple endocrine neoplasia type 2A and 4 more |
branching involved in ureteric bud morphogenesis
GO · q=2.67e-6
|
| Cluster 160 | 9 | Conjunctivitis, Developmental delay with autism spectrum disorder, FAS-related autoimmune lymphoproliferative immune disorder, hypoplasminogenemia, Laryngeal disease and 4 more |
positive regulation of nitric oxide biosynthetic process
GO · q=1.47e-6
|
| Cluster 161 | 9 | bleeding disorder, platelet-type, 22, inherited blood coagulation disorder, Macrothrombocytopenia, macrothrombocytopenia, isolated, 1, autosomal dominant, nizon-isidor syndrome and 4 more |
Platelet activation
Pathway · q=2.67e-17
|
| Cluster 162 | 9 | Auriculocondylar syndrome, Cataract-corneal dystrophy syndrome, Ehlers-Danlos syndrome, spondylocheirodysplastic type, Optic nerve disorder, Paranoid schizophrenia and 4 more |
animal organ morphogenesis
GO · q=1.09e-5
|
| Cluster 163 | 9 | Anodontia, craniofacial dysplasia - osteopenia syndrome, Early-onset epilepsy-intellectual disability-brain anomalies syndrome, Severe neonatal spondylometaphyseal dysplasia, Shwachman-diamond syndrome and 4 more |
cytosolic ribosome assembly
GO · q=9.32e-7
|
| Cluster 164 | 9 | Anti-glomerular basement membrane disease, Aortic arch syndrome, Autoimmune pulmonary alveolar proteinosis, Congenital pulmonary artery atresia, Follicular lymphoma and 4 more |
Autoimmune thyroid disease
Pathway · q=4.26e-9
|
| Cluster 165 | 9 | Asplenia, Congenital asplenia, Congenital septal defect of heart, Congenital-onset steinert myotonic dystrophy, Deletion 5q35 syndrome and 4 more |
endocardial cushion development
GO · q=9.55e-6
|
| Cluster 166 | 9 | Erythematosquamous dermatosis, Ichthyosis vulgaris, intellectual developmental disorder 59, nephrotic syndrome 14, netherton syndrome and 4 more |
melanin biosynthetic process from tyrosine
GO · q=9.65e-5
|
| Cluster 167 | 9 | familial acute necrotizing encephalopathy, hearing impairment and infertile male syndrome, Hyperkalemic periodic paralysis, Male reproductive organ cancer, Myotonia and 4 more |
regulation of skeletal muscle contraction by action potential
GO · q=1.75e-2
|
| Cluster 168 | 9 | Chronic pain, Congenital insensitivity to pain, Congenital pain insensitivity, Episodic pain syndrome, Erythromelalgia and 4 more |
sensory perception of pain
GO · q=2.69e-9
|
| Cluster 169 | 9 | Benign infantile epilepsy, Benign neonatal epilepsy, Benign neonatal-infantile seizures, Cognitive impairment with or without cerebellar ataxia, Hemiplegia and 4 more |
monoatomic ion transport
GO · q=1.20e-4
|
| Cluster 170 | 9 | Congenital leukocyte adherence deficiency, Congenital sensory neuropathy, Cyp2d6 deficiency, Laryngo-onycho-cutaneous syndrome, Leukocyte adhesion deficiency and 4 more |
nerve growth factor signaling pathway
GO · q=3.26e-5
|
| Cluster 171 | 9 | Cervical dystonia, complex movement disorder with or without neurodevelopmental features, Dystonia, Dystonia musculorum deformans, Early-onset generalized limb-onset dystonia and 4 more |
neuromuscular process controlling posture
GO · q=3.27e-4
|
| Cluster 172 | 9 | Carbamoyl phosphate synthetase deficiency, Congenital facial anomaly, Congenital hyperammonemia, Congenital hypoplastic anemia, developmental and epileptic encephalopathy, 50 and 4 more |
'de novo' pyrimidine nucleobase biosynthetic process
GO · q=8.89e-10
|
| Cluster 173 | 9 | Hereditary sensory and autonomic neuropathy, hereditary sensory and autonomic neuropathy type 4, Hereditary sensory and autonomic neuropathy with spastic paraplegia, neuropathy, hereditary sensory and autonomic, type 1A, neuropathy, hereditary sensory and autonomic, type 1C and 4 more |
sensory perception of pain
GO · q=5.65e-7
|
| Cluster 174 | 9 | Childhood ataxia with cns hypomyelination, Congenital or early infantile cach syndrome, Cree leukoencephalopathy, leukoencephalopathy with vanishing white matter 1, leukoencephalopathy with vanishing white matter 2 and 4 more |
Recycling of eIF2:GDP
Pathway · q=2.08e-13
|
| Cluster 175 | 9 | Dna replication fork stabilization factor donson-related microcephaly, short stature, limb abnormalities spectrum, Dwarfism, Ear, patella, short stature syndrome, Meier-gorlin syndrome, meier-gorlin syndrome 2 and 4 more |
Activation of the pre-replicative complex
Pathway · q=2.77e-18
|
| Cluster 176 | 9 | Combined cellular and humoral immune defects with granulomas, Combined immunodeficiency with granulomatosis, Combined immunodeficiency with skin granulomas, free sialic acid storage disease, Omenn syndrome and 4 more |
T cell differentiation in thymus
GO · q=3.84e-11
|
| Cluster 177 | 9 | Hermansky-pudlak syndrome, hermansky-pudlak syndrome 1, hermansky-pudlak syndrome 11, hermansky-pudlak syndrome 2, hermansky-pudlak syndrome 4 and 4 more |
platelet dense granule organization
GO · q=4.88e-22
|
| Cluster 178 | 8 | 15q11.2 microdeletion syndrome, Complex cortical dysplasia with other brain malformations, Congenital fibrosis of extraocular muscles, Cortical development malformation, Cortical dysplasia with other brain malformations and 3 more |
microtubule cytoskeleton organization
GO · q=1.34e-13
|
| Cluster 179 | 8 | 3-hydroxyisobutyric aciduria, Bladder calculus, Dalmatian hypouricemia, Hyperuricemia, Nephrolithiasis and 3 more |
urate metabolic process
GO · q=3.91e-6
|
| Cluster 180 | 8 | 1p21.3 microdeletion syndrome, Anal polyp, Chromosome 2p16.3 deletion syndrome, Dihydropyrimidinase deficiency, Dihydropyrimidine dehydrogenase deficiency and 3 more |
adult behavior
GO · q=2.81e-7
|
| Cluster 181 | 8 | Bile acid malabsorption, Central nervous system disease, Choroidal neovascularization, Diabetes complications, Diabetes microvascular complications and 3 more |
intrinsic apoptotic signaling pathway in response to DNA damage
GO · q=1.23e-5
|
| Cluster 182 | 8 | Agammaglobulinemia, agammaglobulinemia 10, autosomal dominant, agammaglobulinemia 2, autosomal recessive, agammaglobulinemia 3, autosomal recessive, agammaglobulinemia 4, autosomal recessive and 3 more |
B cell differentiation
GO · q=1.19e-8
|
| Cluster 183 | 8 | Aapoai amyloidosis, Apolipoprotein a-i amyloidosis, Apolipoprotein a-i deficiency, Ataxia with vitamin e deficiency, hypercholesterolemia, autosomal dominant, 3 and 3 more |
Cholesterol metabolism
Pathway · q=8.91e-9
|
| Cluster 184 | 8 | Amyloid polyneuropathy, Dystransthyretinemic euthyroidal hyperthyroxinemia, Hyperthyroxinemia, obsolete hereditary ATTR amyloidosis, Senile systemic amyloidosis and 3 more |
HDL remodeling
Pathway · q=2.31e-4
|
| Cluster 185 | 8 | Annular epidermolytic ichthyosis, Congenital reticular ichthyosiform erythroderma, Diffuse nonepidermolytic palmoplantar keratoderma, Epidermolytic hyperkeratosis, Epidermolytic ichthyosis and 3 more |
response to oxidative stress
GO · q=4.85e-8
|
| Cluster 186 | 8 | Achondrogenesis, Atelosteogenesis, De la chapelle dysplasia, Diastrophic dysplasia, Diastrophic dysplasia, broad bone-platyspondylic variant and 3 more |
chondrocyte differentiation
GO · q=2.18e-3
|
| Cluster 187 | 8 | Achondroplasia, Camptodactyly, tall stature, and hearing loss syndrome, Catshl syndrome, Crouzon syndrome with acanthosis nigricans, hypochondroplasia and 3 more |
negative regulation of developmental growth
GO · q=1.93e-3
|
| Cluster 188 | 8 | ACTB-associated syndromic thrombocytopenia, Aminoacylase deficiency, Baraitser-winter cerebrofrontofacial syndrome, Becker nevus syndrome, Congenital smooth muscle hamartoma and 3 more |
EPHB-mediated forward signaling
Pathway · q=7.91e-5
|
| Cluster 189 | 8 | ADAM9-related retinopathy, Age-related macular degeneration, Atrophic macular degeneration, Macular and posterior pole degeneration, Macular degeneration and 3 more |
visual perception
GO · q=2.01e-16
|
| Cluster 190 | 8 | Atypical teratoid rhabdoid tumor, Carotid atherosclerosis, Coffin-siris syndrome, Rhabdoid tumor, Rhabdoid tumor predisposition syndrome and 3 more |
regulation of G0 to G1 transition
GO · q=3.25e-20
|
| Cluster 191 | 8 | Alternating hemiplegia of childhood, Anhedonia, ATP1A3-associated neurological disorder, Capos syndrome, Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss and 3 more |
response to cocaine
GO · q=5.37e-7
|
| Cluster 192 | 8 | Cone-rod synaptic disorder, Early-onset severe hermansky-pudlak syndrome with hearing loss due to ap3d1 deficiency, GPR143-related foveal hypoplasia, hermansky-pudlak syndrome 10, Ocular albinism and 3 more |
melanosome organization
GO · q=1.43e-3
|
| Cluster 193 | 8 | Atrial and intestinal dysrhythmia, Chronobiology disorder, Hyperoxia, Patent ductus venosus, Pruritus and 3 more |
Neuroactive ligand-receptor interaction
Pathway · q=1.93e-6
|
| Cluster 194 | 8 | Androgen insensitivity syndrome, b-cell immunodeficiency, distal limb anomalies, and urogenital malformations, Bulbo-spinal atrophy, x-linked, Kennedy disease, Male breast neoplasms and 3 more |
Pathways in cancer
Pathway · q=4.78e-6
|
| Cluster 195 | 8 | Atrophoderma vermiculata, Burnett schwartz berberian syndrome, Common migraine, Developmental dysplasia of the hip, hypercholesterolemia, familial, 1 and 3 more |
positive regulation of lysosomal protein catabolic process
GO · q=8.07e-4
|
| Cluster 196 | 8 | Angiomatoid fibrous histiocytoma, bleeding disorder, platelet-type, 21, Congenital left-sided heart lesions, Ewing sarcoma, Extraskeletal ewing sarcoma and 3 more |
cAMP/PKA signal transduction
GO · q=6.38e-5
|
| Cluster 197 | 8 | Brain small vessel disease, Cerebral palsy, Cerebral small vessel disease, Congenital porencephaly, Ectopic thyroid tissue and 3 more |
cardiac myofibril assembly
GO · q=6.43e-4
|
| Cluster 198 | 8 | East syndrome, Episodic kinesigenic dyskinesia, Hereditary continuous muscle fiber activity, Littles disease, Paroxysmal dyskinesia and 3 more |
synaptic vesicle maturation
GO · q=7.66e-4
|
| Cluster 199 | 8 | Arthrogryposis, childhood-onset nemaline myopathy, Congenital finger flexion contractures, Digitotalar dysmorphism, Distal arthrogryposis and 3 more |
Striated Muscle Contraction
Pathway · q=6.68e-13
|
| Cluster 200 | 8 | Arthrogryposis with oculomotor limitation and retinal anomalies, Commissural facial cleft, Duplication of pituitary gland, Gorlin syndrome, nevoid basal cell carcinoma syndrome and 3 more |
cell fate determination
GO · q=8.22e-6
|
| Cluster 201 | 8 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium, Cerebellar ataxia, intellectual disability, and dysequilibrium, Cerebellar ataxia, intellectual disability, oculomotor apraxia, cerebellar cysts, Cerebellar ataxia, mental retardation, and dysequilibrium, Cerebellar hypoplasia and 3 more |
involuntary skeletal muscle contraction
GO · q=1.09e-2
|
| Cluster 202 | 8 | Atrophy, Copper overload cirrhosis, hyper-IgE recurrent infection syndrome 1, autosomal dominant, Hyper-ige syndrome, Hyper-immunoglobulin e syndrome and 3 more |
Proteoglycans in cancer
Pathway · q=6.04e-9
|
| Cluster 203 | 8 | autosomal dominant slowed nerve conduction velocity, Benign fasciculation-cramp syndrome, Bronchial hyperreactivity, Charcot-Marie-Tooth disease axonal type 2F, Cramp-fasciculation syndrome and 3 more |
antimicrobial humoral immune response mediated by antimicrobial peptide
GO · q=3.89e-7
|
| Cluster 204 | 8 | Autoimmune neurological syndrome, Axonal hereditary motor and sensory neuropathy, Charcot-Marie-Tooth disease dominant intermediate E, Charcot-Marie-Tooth disease type 2A2, Hereditary motor and sensory neuropathy and 3 more |
late endosome to vacuole transport via multivesicular body sorting pathway
GO · q=9.64e-3
|
| Cluster 205 | 8 | Congenital myelofibrosis with anemia, Congenital neutropenia, immunodeficiency 76, Neutropenia, Neutropenia, nonimmune chronic idiopathic, adult and 3 more |
SRP-dependent cotranslational protein targeting to membrane
GO · q=5.49e-8
|
| Cluster 206 | 8 | Clouston syndrome, Deafness, x-linked, Hearing loss with stapes fixation, ichthyosiform erythroderma, corneal involvement, and hearing loss, Keratitis-ichthyosis-deafness syndrome and 3 more |
gap junction-mediated intercellular transport
GO · q=2.91e-4
|
| Cluster 207 | 8 | Basal cell nevus syndrome, Bifid nose, Cleft face, Culler-jones syndrome, Desanto-shinawi syndrome and 3 more |
spinal cord dorsal/ventral patterning
GO · q=3.54e-6
|
| Cluster 208 | 8 | Blue cone monochromatism, Cone dystrophy, x-linked, Cone monochromatism, Deuteranomaly, red color blindness and 3 more |
absorption of visible light
GO · q=9.17e-12
|
| Cluster 209 | 8 | Brachyolmia, Brachyrachia, Congenital benign spinal muscular atrophy, Digital arthropathy-brachydactyly, familial, Parastremmatic dwarfism and 3 more |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
GO · q=3.38e-4
|
| Cluster 210 | 8 | Combined pituitary hormone deficiency, Congenital hypopituitarism, Growth hormone deficiency with pituitary anomalies, hypogonadotropic hypogonadism 3 with or without anosmia, Pituitary hormone deficiency and 3 more |
pituitary gland development
GO · q=1.86e-10
|
| Cluster 211 | 8 | Central nervous system demyelinating disease, Deafness enamel hypoplasia nail defects, Deafness-enamel hypoplasia-nail defects syndrome, dilated cardiomyopathy 2B, Heimler syndrome and 3 more |
protein import into peroxisome matrix, receptor recycling
GO · q=7.22e-7
|
| Cluster 212 | 8 | Cerebelloparenchymal disorder, Lactic acidosis, Normal pressure hydrocephalus, primary ciliary dyskinesia, Ptosis and 3 more |
cilium movement involved in cell motility
GO · q=6.49e-7
|
| Cluster 213 | 8 | dilated cardiomyopathy 1G, Early-onset myopathy with fatal cardiomyopathy, Feingold syndrome, myopathy, myofibrillar, 9, with early respiratory failure, Progressive contractures limb-girdle weakness muscle dystrophy syndrome and 3 more |
skeletal muscle myosin thick filament assembly
GO · q=7.18e-3
|
| Cluster 214 | 8 | Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome, encephalopathy, progressive, with amyotrophy and optic atrophy, Kenny caffey syndrome, Kenny-caffey syndrome and 3 more |
post-chaperonin tubulin folding pathway
GO · q=9.72e-5
|
| Cluster 215 | 7 | Congenital cataract hearing loss developmental delay syndrome, developmental and epileptic encephalopathy, 77, Epilepsy, Generalized epilepsy, Partial epilepsy and 2 more |
chemical synaptic transmission
GO · q=4.57e-34
|
| Cluster 216 | 7 | Adrenal gland neoplasms, Cobblestone lissencephaly, Corneal disease, Corneal edema, Paranoia and 2 more |
MET activates PTK2 signaling
Pathway · q=1.89e-3
|
| Cluster 217 | 7 | 17p13.3 microduplication syndrome, Chromosome 17p13.3 microdeletion syndrome, Clear cell sarcoma of kidney, Endometrial stromal sarcoma, microphthalmia, syndromic 2 and 2 more |
negative regulation of transcription by RNA polymerase II
GO · q=8.31e-3
|
| Cluster 218 | 7 | 8q24.3 microdeletion syndrome, Charge syndrome, Congenital heart defect, intellectual disability, facial dysmorphism syndrome, Diets-jongmans syndrome, Intellectual developmental disorder dysmorphic cardiac short stature and 2 more |
chromatin organization
GO · q=6.74e-9
|
| Cluster 219 | 7 | Dentici novelli neurodevelopmental syndrome, Hepatic veno occlusive disease with immunodeficiency, Hodgkin lymphoma, Lymphocytic b-cell leukemia, Lymphocytic leukemia and 2 more |
response to gamma radiation
GO · q=1.46e-7
|
| Cluster 220 | 7 | Cholelithiasis, Hyperbiliverdinemia, hyperphenylalaninemia due to DNAJC12 deficiency, Liver cirrhosis, Liver disease and 2 more |
AGE-RAGE signaling pathway in diabetic complications
Pathway · q=7.22e-25
|
| Cluster 221 | 7 | Alys amyloidosis, Amyloidosis, amyloidosis, hereditary systemic 6, Beta2-microglobulinic amyloidosis, Hypergammaglobulinemia and 2 more |
Amyloid fiber formation
Pathway · q=4.67e-10
|
| Cluster 222 | 7 | Abeta amyloidosis, Amyloid angiopathy, Amyloid neuropathy, cerebral amyloid angiopathy, app-related, Early onset alzheimers disease with behavioral disturbance and 2 more |
astrocyte activation involved in immune response
GO · q=2.26e-5
|
| Cluster 223 | 7 | Absence epilepsy, Ataxia, Childhood absence epilepsy, Conn syndrome, Idiopathic generalized epilepsy and 2 more |
monoatomic ion transport
GO · q=5.84e-20
|
| Cluster 224 | 7 | Cranio-cervical dystonia, Dravet syndrome, Febrile convulsion, Female restricted epilepsy with intellectual disability, Generalized epilepsy with febrile seizures plus and 2 more |
monoatomic ion transmembrane transport
GO · q=3.37e-11
|
| Cluster 225 | 7 | Aceruloplasminemia, Apoceruloplasmin deficiency, Ferroxidase deficiency, hemochromatosis type 4, Hemosiderosis and 2 more |
intracellular iron ion homeostasis
GO · q=3.74e-11
|
| Cluster 226 | 7 | Acral self-healing collodion baby, Congenital ichthyosiform erythroderma, Congenital ichthyosis, Congenital ichthyosis with hypotrichosis syndrome, Congenital nonbullous ichthyosiform erythroderma and 2 more |
establishment of skin barrier
GO · q=2.56e-9
|
| Cluster 227 | 7 | Acromegaloid facial appearance syndrome, Cantu syndrome, dilated cardiomyopathy 1O, Hypertrichosis, hypertrichotic osteochondrodysplasia Cantu type and 2 more |
ATP sensitive Potassium channels
Pathway · q=5.64e-7
|
| Cluster 228 | 7 | Acromegaly, Chromosome xq26.3 duplication syndrome, Growth hormone-secreting pituitary adenoma, multiple endocrine neoplasia type 1, Pituitary adenoma and 2 more |
adenylate cyclase-activating adrenergic receptor signaling pathway
GO · q=5.66e-4
|
| Cluster 229 | 7 | Alagille syndrome, Corneal opacity, Deafness with congenital heart defects and posterior embryotoxon, Eye abnormalities, frank-ter haar syndrome and 2 more |
Pathways in cancer
Pathway · q=4.66e-6
|
| Cluster 230 | 7 | Cutaneous mastocytosis, Intellectual developmental disorder growth seizures, isovaleric acidemia, Mastocytosis, Secondary malignant neoplasm and 2 more |
'de novo' UMP biosynthetic process
GO · q=1.34e-5
|
| Cluster 231 | 7 | Auricle malformation, Degcags syndrome, Diamond-blackfan anemia, diamond-blackfan anemia 6, Erythroid hypoplasia and 2 more |
cytoplasmic translation
GO · q=2.80e-35
|
| Cluster 232 | 7 | Adenosine kinase deficiency, Glycine n-methyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency, hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, methionine adenosyltransferase deficiency and 2 more |
one-carbon metabolic process
GO · q=8.91e-7
|
| Cluster 233 | 7 | Adenylosuccinate lyase deficiency, Cholecystitis, Cholecystolithiasis, cone-rod dystrophy 20, Gallstones and 2 more |
Bile secretion
Pathway · q=1.81e-18
|
| Cluster 234 | 7 | Cerebellar atrophy, Congenital cataract microcephaly intellectual disability syndrome, Congenital cerebellar hypoplasia, Dysarthria, Polyneuropathy and 2 more |
response to hyperoxia
GO · q=6.22e-4
|
| Cluster 235 | 7 | Corneal astigmatism, Deeah syndrome, Diaphanospondylodysostosis, Glaucoma, neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus and 2 more |
positive regulation of transcription by RNA polymerase II
GO · q=7.51e-8
|
| Cluster 236 | 7 | Aicardi goutieres syndrome, Chilblain lupus, Chilblain lupus erythematosus, Deoxyguanosine kinase deficiency, Interferonopathy and 2 more |
mismatch repair
GO · q=5.17e-7
|
| Cluster 237 | 7 | Aland island eye disease, CACNA1F-related retinopathy, Ciliary dyskinesia with retinitis pigmentosa, Cone-rod dystrophy, x-linked, Retinitis pigmentosa, x-linked, and sinorespiratory infections with or without deafness and 2 more |
visual perception
GO · q=3.80e-3
|
| Cluster 238 | 7 | Bell's palsy, Charcot-Marie-Tooth disease axonal type 2CC, Giant axonal neuropathy, Nervous system disease, Non-neoplastic peripheral nervous system disease and 2 more |
Antifolate resistance
Pathway · q=1.10e-8
|
| Cluster 239 | 7 | Allan-herndon-dudley syndrome, complex hereditary spastic paraplegia, Hereditary spastic paraplegia, hereditary spastic paraplegia 11, hereditary spastic paraplegia 18 and 2 more |
vesicle-mediated transport
GO · q=2.11e-4
|
| Cluster 240 | 7 | Alpha-1 antitrypsin deficiency, Asbestosis, Beriberi, Gastro-entero-pancreatic neuroendocrine tumor, immunodeficiency 63 with lymphoproliferation and autoimmunity and 2 more |
cellular response to lipopolysaccharide
GO · q=2.99e-6
|
| Cluster 241 | 7 | Congenital nemaline myopathy, Nemaline myopathy, nemaline myopathy 10, nemaline myopathy 6, nemaline myopathy 7 and 2 more |
Cytoskeleton in muscle cells
Pathway · q=1.00e-12
|
| Cluster 242 | 7 | Bilateral vestibulopathy, Cerebellar ataxia with neuropathy and bilateral vestibular areflexia, Cerebellar ataxia, neuropathy, and vestibular areflexia, Charcot-Marie-Tooth disease type 4, Hereditary sensory and motor neuropathy and 2 more |
EGR2 and SOX10-mediated initiation of Schwann cell myelination
Pathway · q=1.22e-7
|
| Cluster 243 | 7 | ALS2-related motor neuron disease, Beta-mannosidosis, glutaryl-CoA dehydrogenase deficiency, hawkinsinuria, Hypertyrosinemia and 2 more |
Tyrosine catabolism
Pathway · q=2.82e-7
|
| Cluster 244 | 7 | Comp-related skeletal dysplasia, Epiphyseal dysplasia, Laryngeal hypoplasia, Marshall syndrome, Stickler syndrome and 2 more |
Collagen biosynthesis and modifying enzymes
Pathway · q=4.63e-14
|
| Cluster 245 | 7 | Chromosome 16p13.3 deletion syndrome, Congenital cleft hand, Congenital malformation syndromes predominantly involving limbs, fanconi anemia complementation group l, Rubinstein-taybi syndrome and 2 more |
positive regulation of transcription by RNA polymerase II
GO · q=2.65e-8
|
| Cluster 246 | 7 | Ayazi syndrome, Choroideremia-deafness-obesity syndrome, Chromosome xq21 deletion syndrome, Deafness, aminoglycoside-induced, Deafness, nonsyndromic sensorineural, mitochondrial and 2 more |
aerobic respiration
GO · q=2.57e-3
|
| Cluster 247 | 7 | anterior segment dysgenesis 4, Axenfeld anomaly, Axenfeld-rieger syndrome, FOXC1-related anterior segment dysgenesis, Iridogoniodysgenesis and 2 more |
brain development
GO · q=8.10e-5
|
| Cluster 248 | 7 | Anisometropia, Concussion, Lipomatosis, maturity-onset diabetes of the young type 8, PTEN hamartoma tumor syndrome and 2 more |
DNA damage checkpoint signaling
GO · q=4.62e-3
|
| Cluster 249 | 7 | Anonychia, Bent bone dysplasia, Campomelic dysplasia, Camptomelic dysplasia, Cooks syndrome and 2 more |
prostate gland morphogenesis
GO · q=7.40e-5
|
| Cluster 250 | 7 | Apolipoprotein a5 deficiency, congenital disorder of glycosylation, type iit, Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies, Hyperlipidemia, Hypertriglyceridemia and 2 more |
Cholesterol metabolism
Pathway · q=2.10e-18
|
| Cluster 251 | 7 | Arts syndrome, Ataxia with deafness and vision loss, phosphoribosylpyrophosphate synthetase superactivity, Prpp synthetase superactivity, PRPS1 deficiency disorder and 2 more |
subthalamic nucleus development
GO · q=6.32e-3
|
| Cluster 252 | 7 | Beckwith-wiedemann syndrome, Childhood apraxia of speech, Chorioretinal atrophy, Chromosomal disorder, Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome and 2 more |
insulin-like growth factor receptor signaling pathway
GO · q=8.97e-6
|
| Cluster 253 | 7 | Arachnoid cysts, Benign mesial temporal lobe epilepsy, Corpus callosum agenesis with abnormal genitalia, Lissencephaly, x-linked, Periventricular heterotopia and 2 more |
glycine receptor clustering
GO · q=8.77e-3
|
| Cluster 254 | 7 | Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Hyperbilirubinemia, Lucey-driscoll syndrome and 2 more |
negative regulation of fatty acid metabolic process
GO · q=7.26e-22
|
| Cluster 255 | 7 | arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Carvajal syndrome, Erythrokeratodermia-cardiomyopathy syndrome, Lethal acantholytic epidermolysis bullosa, Naxos disease and 2 more |
regulation of ventricular cardiac muscle cell action potential
GO · q=3.16e-7
|
| Cluster 256 | 7 | Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Bockenheimer syndrome, Congenital venous anomaly, Mucocutaneous venous malformations and 2 more |
Tie2 Signaling
Pathway · q=1.90e-5
|
| Cluster 257 | 7 | Autoinflammation with infantile enterocolitis, Cria syndrome, Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infection syndrome, Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infection-lymphopenia syndrome, immunodeficiency 57 and 2 more |
interleukin-10-mediated signaling pathway
GO · q=7.53e-7
|
| Cluster 258 | 7 | Congenital cranial dysinnervation disorder, Cryptogenic multifocal ulcerous stenosing enteritis, Curling ulcer, Cytosolic phospholipase-a2 alpha deficiency associated bleeding disorder, Diffuse gastric adenocarcinoma and 2 more |
response to estradiol
GO · q=2.53e-4
|
| Cluster 259 | 7 | Epilepsy with auditory features, Familial temporal lobe epilepsy, Lateral temporal lobe epilepsy, lissencephaly with cerebellar hypoplasia, Sacroiliac arthritis and 2 more |
Neuroactive ligand-receptor interaction
Pathway · q=2.74e-12
|
| Cluster 260 | 7 | Benign samaritan congenital myopathy, Central core disease, Central core myopathy, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia and 2 more |
cellular response to caffeine
GO · q=3.21e-5
|
| Cluster 261 | 7 | Bernard-soulier syndrome, Cerebral thrombosis, hereditary von Willebrand disease, Intracranial thrombosis, platelet-type bleeding disorder 8 and 2 more |
blood coagulation
GO · q=3.58e-19
|
| Cluster 262 | 7 | Carnitine acetyltransferase deficiency, Hallervorden spatz syndrome, hereditary spastic paraplegia 35, kufor-rakeb syndrome, Neurodegeneration with brain iron accumulation and 2 more |
intracellular iron ion homeostasis
GO · q=5.22e-5
|
| Cluster 263 | 7 | Bilateral frontoparietal polymicrogyria, Bilateral perisylvian polymicrogyria, Combined immunodeficiency-multiple intestinal atresia, Combined immunodeficiency, enteropathy spectrum, Gastrointestinal defects and immunodeficiency syndrome and 2 more |
phosphatidylinositol phosphate biosynthetic process
GO · q=3.27e-3
|
| Cluster 264 | 7 | Clonal cytopenia of undetermined significance, coffin-lowry syndrome, Developmental delay with behavioral abnormalities, heyn-sproul-jackson syndrome, Microcephalic dwarfism and 2 more |
ERBB signaling pathway
GO · q=2.10e-4
|
| Cluster 265 | 7 | Birk-barel syndrome, cataract 50 with or without glaucoma, Cataract-glaucoma syndrome, Congenital cataract anterior segment dysgenesis syndrome, Mulibrey nanism and 2 more |
regulation of interleukin-1 production
GO · q=1.50e-2
|
| Cluster 266 | 7 | Bleeding esophageal varices, Dyshidrosis, Esophageal and gastric varices, Esophageal varices, Portal hypertension and 2 more |
negative regulation of cell-cell adhesion
GO · q=5.37e-3
|
| Cluster 267 | 7 | Bundle branch block, Cerebral atrophy, Coronary aneurysm, Dock2 deficiency, Intellectual developmental disorder expressive speech dysmorphic and 2 more |
cerebral cortex radially oriented cell migration
GO · q=8.87e-3
|
| Cluster 268 | 7 | Blepharophimosis-ptosis-epicanthus inversus syndrome, Dicer1 syndrome, Dicer1 tumor-predisposition syndrome, Dicer1-related tumor predisposition, Granulosa cell tumor of ovary and 2 more |
apoptotic DNA fragmentation
GO · q=9.27e-5
|
| Cluster 269 | 7 | Bronchiectasis, congenital disorder of glycosylation, type 2v, Liddle syndrome, pseudohypoaldosteronism type 2D, pseudohypoaldosteronism type 2E and 2 more |
multicellular organismal-level water homeostasis
GO · q=3.50e-7
|
| Cluster 270 | 7 | Cataract-microcornea-metabolic syndrome, Cleft eyelid, Coloboma, Congenital iris coloboma, Congenital ocular coloboma and 2 more |
eye development
GO · q=2.21e-6
|
| Cluster 271 | 7 | Childhood-onset epilepsy syndrome, familial sleep-related hypermotor epilepsy, Focal onset epileptic seizure, Frontal lobe epilepsy, intellectual disability, autosomal dominant 42 and 2 more |
monoatomic ion transport
GO · q=3.47e-7
|
| Cluster 272 | 7 | Donohue syndrome, Insulin resistant diabetes mellitus, Insulin resistant diabetes mellitus with acanthosis nigricans, insulin-resistance syndrome type A, Insulin-resistant diabetes mellitus with acanthosis nigricans and 2 more |
glucose homeostasis
GO · q=1.86e-3
|
| Cluster 273 | 7 | Chronic infantile diarrhea due to guanylate cyclase 2c overactivity, Congenital chloride diarrhea, Congenital chronic diarrhea with protein-losing enteropathy, Congenital diarrhea, Congenital secretory diarrhea and 2 more |
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)
Pathway · q=1.21e-2
|
| Cluster 274 | 7 | Intestinal pseudo-obstruction, Megacystis microcolon intestinal hypoperistalsis syndrome, microcephaly with lissencephaly and/or hydranencephaly, Microhydranencephaly, Tricuspid valve disease and 2 more |
Smooth Muscle Contraction
Pathway · q=2.01e-7
|
| Cluster 275 | 7 | ciliary dyskinesia, primary, 45, Congenital impairment of spermatozoa motility, Male infertility teratozoospermia, Ruijs-aalfs syndrome, spermatogenic failure 38 and 2 more |
sperm axoneme assembly
GO · q=1.45e-16
|
| Cluster 276 | 7 | L1 syndrome, Masa syndrome, Partial corpus callosum agenesis, x-linked, X-linked complicated corpus callosum dysgenesis, X-linked complicated spastic paraplegia and 2 more |
Recycling pathway of L1
Pathway · q=9.03e-4
|
| Cluster 277 | 7 | Corpus callosum agenesis with facial anomalies and cerebellar ataxia, Craniofacial microsomia, Deafness with congenital inner ear agenesis, microtia, and microdontia, Deafness with labyrinthine aplasia, microtia, and microdontia, Intestinal dysmotility syndrome and 2 more |
protein localization to membrane
GO · q=7.07e-3
|
| Cluster 278 | 7 | Cortical dysplasia, Cortical occipital malformations, Developmental delay with language impairment and movement disorder, Intellectual developmental disorder autism speech, Intellectual developmental disorder language neurodegenerative and 2 more |
adult locomotory behavior
GO · q=7.07e-3
|
| Cluster 279 | 7 | Corticosterone methyl oxidase type i, Corticosterone methyloxidase deficiency, Corticosterone monooxygenase deficiency, Familial hypoaldosteronism, Glucocorticoid-remediable aldosteronism and 2 more |
aldosterone biosynthetic process
GO · q=2.70e-6
|
| Cluster 280 | 7 | Erythrocyte galactose epimerase deficiency, Erythrocyte udp-galactose-4-epimerase deficiency, galactose epimerase deficiency, Galactose mutarotase deficiency, Galactosemia and 2 more |
galactose catabolic process via UDP-galactose, Leloir pathway
GO · q=7.36e-13
|
| Cluster 281 | 6 | Anti-nmda receptor encephalitis, Birdshot chorioretinopathy, Carbamazepine hypersensitivity, Paraparesis, Thrombophlebitis and 1 more |
antigen processing and presentation of peptide antigen via MHC class I
GO · q=4.48e-7
|
| Cluster 282 | 6 | acute myeloid leukemia, ciliary dyskinesia, primary, 44, hearing loss, autosomal recessive, Hoarding disorder, Pericarditis and 1 more |
sensory perception of sound
GO · q=9.95e-3
|
| Cluster 283 | 6 | 12q14 microdeletion syndrome, Buschke-ollendorff syndrome, Dermatofibrosis lenticularis disseminata, Osteopoikilosis, qualitative platelet defect and 1 more |
mesodermal-endodermal cell signaling
GO · q=8.02e-3
|
| Cluster 284 | 6 | 14q11.2 microduplication syndrome, Chromodomain helicase dna binding protein 8 overgrowth syndrome, Congenital corneal opacity, Congenital ptosis, FOXG1 disorder and 1 more |
brain development
GO · q=1.41e-4
|
| Cluster 285 | 6 | Congenital retrognathism, greenberg dysplasia, Pelger-huet anomaly, regressive spondylometaphyseal dysplasia, Reynolds syndrome and 1 more |
face morphogenesis
GO · q=2.19e-3
|
| Cluster 286 | 6 | Adult myoclonic epilepsy, Benign adult familial myoclonic epilepsy, Benign myoclonic epilepsy, Early onset epilepsy with developmental delay, Familial adult myoclonic epilepsy and 1 more |
monoatomic ion transmembrane transport
GO · q=2.68e-6
|
| Cluster 287 | 6 | Amblyopia, Christianson syndrome, CNGB1-related retinopathy, Neurodegenerative disorder, x-linked, female-restricted, with parkinsonism and cognitive impairment, neurodevelopmental disorder with severe motor impairment and absent language and 1 more |
negative regulation of osteoclast differentiation
GO · q=1.39e-4
|
| Cluster 288 | 6 | Abruzzo-erickson syndrome, Cleft palate with ankyloglossia, Cleft palate x-linked, fanconi anemia complementation group d2, Uranostaphyloschisis and 1 more |
positive regulation of neuron migration
GO · q=4.94e-3
|
| Cluster 289 | 6 | Berylliosis, Cervical disc degenerative disorder, Gouty arthritis, Intervertebral disc disease, Trigeminal neuralgia and 1 more |
AGE-RAGE signaling pathway in diabetic complications
Pathway · q=3.80e-13
|
| Cluster 290 | 6 | Astrocytoma, Central nervous system cancer, Glioblastoma, Glioma, systemic lupus erythematosus 18 and 1 more |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
GO · q=2.09e-6
|
| Cluster 291 | 6 | Autoinflammatory-pancytopenia syndrome, Diabetes mellitus type 1, Hypothyroidism, Rheumatoid arthritis, Sarcoidosis and 1 more |
immune response
GO · q=8.68e-29
|
| Cluster 292 | 6 | Apolipoprotein c-ii deficiency, Arteriosclerosis, Corneal injury, Hypercholesterolemia, hypercholesterolemia, familial, 4 and 1 more |
cholesterol homeostasis
GO · q=8.68e-29
|
| Cluster 293 | 6 | Autism, x-linked, Benign paroxysmal torticollis of infancy, Bulbar palsy, Central apnea, Episodic ataxia and 1 more |
chemical synaptic transmission
GO · q=2.72e-6
|
| Cluster 294 | 6 | Acatalasia, amyotrophic lateral sclerosis type 1, Aortic disease, Bonnevie-ullrich syndrome, Turner syndrome and 1 more |
Detoxification of Reactive Oxygen Species
Pathway · q=7.26e-7
|
| Cluster 295 | 6 | Achromatopsia, ATF6-related retinopathy, CNGA3-related retinopathy, CNGB3-related retinopathy, GNAT2-related retinopathy and 1 more |
visual perception
GO · q=5.25e-9
|
| Cluster 296 | 6 | Charcot-Marie-tooth disease, axonal, type 2DD, Cushing syndrome, Cushing's disease, DDOST-congenital disorder of glycosylation, Hyperaldosteronism and 1 more |
Cushing syndrome
Pathway · q=1.15e-7
|
| Cluster 297 | 6 | Antecubital pterygium syndrome, Apolipoprotein c-iii deficiency, Cholesterol ester transfer protein deficiency, Follicular cyst, Hyperalphalipoproteinemia and 1 more |
reverse cholesterol transport
GO · q=3.49e-5
|
| Cluster 298 | 6 | Ameloblastoma, Congenital hypothalamic hamartoma syndrome, Curry-jones syndrome, Meningioma, mosaic SMO syndrome and 1 more |
Hepatocellular carcinoma
Pathway · q=2.84e-6
|
| Cluster 299 | 6 | aortic valve disease 3, Bicuspid aortic valve, Congenital erythroderma with palmoplantar keratoderma, hypotrichosis, and hyper-ige, Diffuse palmoplantar keratoderma, Focal palmoplantar keratoderma with joint keratoses and 1 more |
aortic valve morphogenesis
GO · q=4.43e-6
|
| Cluster 300 | 6 | alacrima, achalasia, and intellectual disability syndrome, Glucocorticoid deficiency with achalasia, Intellectual developmental disorder dysmorphic strabismus, Intellectual developmental disorder movement cerebellar, Intellectual disability with strabismus syndrome and 1 more |
negative regulation of phosphate metabolic process
GO · q=6.32e-3
|
| Cluster 301 | 6 | Alanine-glyoxylate aminotransferase deficiency, Brachydactyly-elbow wrist dysplasia syndrome, Hyperoxaluria, mucopolysaccharidosis type 1, Pfaundler-hurler syndrome and 1 more |
glyoxylate metabolic process
GO · q=6.35e-7
|
| Cluster 302 | 6 | Alazami-yuan syndrome, Congenital muscular hypertrophy-cerebral syndrome, Cornelia de lange syndrome, De lange syndrome, Wiedemann-steiner syndrome and 1 more |
establishment of mitotic sister chromatid cohesion
GO · q=1.94e-9
|
| Cluster 303 | 6 | Albinism, Eye neoplasms, Oculocutaneous albinism, Prader-willi syndrome, Rufous oculocutaneous albinism and 1 more |
melanin biosynthetic process
GO · q=4.22e-14
|
| Cluster 304 | 6 | alkylglycerone-phosphate synthase deficiency, Chondrodysplasia, chondrodysplasia with joint dislocations, gpapp type, glyceronephosphate O-acyltransferase deficiency, Rhizomelic chondrodysplasia punctata and 1 more |
ether lipid biosynthetic process
GO · q=5.83e-6
|
| Cluster 305 | 6 | Alpha-1 antichymotrypsin deficiency, Hemolytic disease of fetus and newborn, Rh deficiency syndrome, Rh isoimmunization, Rh-null, amorph type and 1 more |
ammonium homeostasis
GO · q=4.88e-8
|
| Cluster 306 | 6 | Alpha-actinopathy, Congenital fiber type disproportion myopathy, Eichsfeld type congenital muscular dystrophy, Rigid spine muscular dystrophy, SELENON-related myopathy and 1 more |
muscle contraction
GO · q=2.82e-7
|
| Cluster 307 | 6 | Amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia, Thrombocythemia, Thrombocythemia with distal limb defects and 1 more |
thrombopoietin-mediated signaling pathway
GO · q=3.43e-9
|
| Cluster 308 | 6 | Charcot-Marie-Tooth disease, demyelinating, type 1J, Graves disease, Hashimoto disease, Hyperthyroidism, Thyroid disease and 1 more |
Autoimmune thyroid disease
Pathway · q=4.19e-23
|
| Cluster 309 | 6 | Benign concentric annular macular dystrophy, Distal myopathy, IMPG1-related dominant retinopathy, IMPG1-related recessive retinopathy, IMPG2-related recessive retinopathy and 1 more |
detection of muscle stretch
GO · q=6.33e-4
|
| Cluster 310 | 6 | amyotrophic lateral sclerosis type 11, Bilateral parasagittal parieto-occipital polymicrogyria, Childhood-onset basal ganglia degeneration syndrome, hypogonadotropic hypogonadism 1 with or without anosmia, Micropenis and 1 more |
Synthesis of PIPs at the late endosome membrane
Pathway · q=2.31e-4
|
| Cluster 311 | 6 | Boichis syndrome, Cerebellar malformation, Chylomicron retention disease, Coach syndrome, Rhyns syndrome and 1 more |
cilium assembly
GO · q=3.03e-8
|
| Cluster 312 | 6 | Dominant dystrophic epidermolysis bullosa with absence of skin, Dominant dystrophic epidermolysis bullosa, albopapular type, Duane retraction syndrome, Dystrophic epidermolysis bullosa, Hallopeau siemens disease and 1 more |
motor neuron axon guidance
GO · q=4.47e-3
|
| Cluster 313 | 6 | Antithrombin deficiency, Bronchiolitis, Craniocerebral trauma, Diffuse panbronchiolitis, Hereditary antithrombin deficiency and 1 more |
IL-17 signaling pathway
Pathway · q=5.01e-4
|
| Cluster 314 | 6 | cardiomyopathy, dilated, 2k, COG6-congenital disorder of glycosylation, Juvenile arthritis, Juvenile idiopathic arthritis, Oligoarticular juvenile idiopathic arthritis and 1 more |
Th17 cell differentiation
Pathway · q=8.33e-12
|
| Cluster 315 | 6 | Blepharophimosis syndrome, Blepharophimosis-intellectual disability syndrome, Cholestasis-pigmentary retinopathy-cleft palate syndrome, KAT6B-related multiple congenital anomalies syndrome, MED12-related intellectual disability syndrome and 1 more |
positive regulation of DNA-templated transcription
GO · q=2.02e-4
|
| Cluster 316 | 6 | ARHGAP29-related non-syndromic orofacial cleft, Bilateral cleft lip, Blepharocheilodontic syndrome, Cleft lip with or without cleft palate, Hereditary diffuse gastric and lobular breast cancer syndrome and 1 more |
cell-cell adhesion mediated by cadherin
GO · q=1.25e-6
|
| Cluster 317 | 6 | CEP290-related ciliopathy, Encephalocele, intellectual disability, autosomal recessive 61, joubert syndrome 17, obsolete Stüve-Wiedemann syndrome and 1 more |
leukemia inhibitory factor signaling pathway
GO · q=9.94e-5
|
| Cluster 318 | 6 | Arteritis, Central retinal vein occlusion, Congenital thrombotic thrombocytopenic purpura, hereditary thrombophilia due to congenital protein C deficiency, Three-vessel coronary artery disease and 1 more |
response to toxic substance
GO · q=1.99e-4
|
| Cluster 319 | 6 | Capillary leak syndrome, Coronary artery vasospasm, Coronary vasospasm, Intestinal perforation, Resistant hypertension and 1 more |
Nitric oxide stimulates guanylate cyclase
Pathway · q=1.17e-4
|
| Cluster 320 | 6 | Arthralgia, Bone marrow neoplasms, Hyper-igd syndrome, Hyper-immunoglobulin d syndrome, methylmalonic aciduria, cblb type and 1 more |
isoprenoid biosynthetic process
GO · q=2.79e-4
|
| Cluster 321 | 6 | Arthrogryposis with ectodermal dysplasia, hearing loss, autosomal recessive 116, Pendred syndrome, progressive microcephaly-seizures-cortical blindness-developmental delay syndrome, Sensorineural hearing loss thrombocytopenia syndrome and 1 more |
sensory perception of sound
GO · q=4.96e-7
|
| Cluster 322 | 6 | autosomal recessive osteopetrosis 2, Bone resorption, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Contracture, Hyaline fibromatosis and 1 more |
ossification
GO · q=2.66e-5
|
| Cluster 323 | 6 | Blau syndrome, Bronchiolitis obliterans, Granulomatous inflammatory arthritis-dermatitis-uveitis, familial, Intestinal disease, Peritonitis and 1 more |
positive regulation of interleukin-8 production
GO · q=1.06e-4
|
| Cluster 324 | 6 | Atrioventricular excitation abnormality, Bile duct disorder, dilated cardiomyopathy 1EE, Keppen-lubinsky syndrome, MYH-6 related congenital heart defects and 1 more |
Oxytocin signaling pathway
Pathway · q=2.46e-3
|
| Cluster 325 | 6 | Benign recurrent intrahepatic cholestasis, Intrahepatic cholestasis, Intrahepatic cholestasis of pregnancy, mednik syndrome, progressive familial intrahepatic cholestasis type 3 and 1 more |
Bile secretion
Pathway · q=4.29e-10
|
| Cluster 326 | 6 | Intellectual developmental disorder microcephaly cerebellar, intellectual disability, X-linked 107, Partington syndrome, X-linked female restricted facial dysmorphism, short stature, choanal atresia, intellectual disability, X-linked myopathy with excessive autophagy and 1 more |
rhythmic process
GO · q=4.51e-3
|
| Cluster 327 | 6 | Autoimmune hemolytic anemia, Autoimmune thrombocytopenic purpura, Autoimmunity-autoinflammation-immunodeficiency syndrome, Autoinflammatory syndrome with immunodeficiency, Autoinflammatory syndrome, familial, with or without immunodeficiency and 1 more |
positive regulation of Wnt signaling pathway, planar cell polarity pathway
GO · q=2.70e-3
|
| Cluster 328 | 6 | Autosomal dominant sensorineural deafness, Hearing loss with hypertrophic cardiomyopathy, Lobular carcinoma, macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Renal hypertension and 1 more |
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger
GO · q=6.82e-5
|
| Cluster 329 | 6 | Bart-pumphrey syndrome, Deafness, digenic, Keratitis ichthyosis hearing loss syndrome, Peripheral neuropathy with sensorineural hearing impairment syndrome, Vohwinkel syndrome and 1 more |
peptide cross-linking
GO · q=7.15e-4
|
| Cluster 330 | 6 | Chromosome 10q deletion syndrome, Developmental delay with ataxia, hypotonia, and facial dysmorphism, Developmental regression, Hepatoencephalopathy due to combined oxidative phosphorylation defect, hypotonia, ataxia, and delayed development syndrome and 1 more |
gallbladder development
GO · q=4.56e-4
|
| Cluster 331 | 6 | combined immunodeficiency due to MALT1 deficiency, Congenital aortic valve atresia, Congenital mitral valve atresia, Intellectual developmental disorder language autism, Intellectual developmental disorder seizures hypotonia skeletal and 1 more |
response to fungus
GO · q=1.03e-4
|
| Cluster 332 | 6 | Benta disease, Congenital cardiovascular anomaly, Fanconi anemia complementation group C, immunodeficiency 11b with atopic dermatitis, Osteopenia and 1 more |
response to peptide hormone
GO · q=7.04e-3
|
| Cluster 333 | 6 | Beta-ureidopropionase deficiency, Cryptogenic west syndrome, Epilepsy due to perinatal stroke, Infantile spasms, medium chain acyl-coa dehydrogenase deficiency and 1 more |
cerebral cortex development
GO · q=4.26e-5
|
| Cluster 334 | 6 | Lafora disease, Myoclonus-renal failure syndrome, Progressive myoclonic epilepsy, Progressive myoclonic epilepsy with renal failure, progressive myoclonus epilepsy and 1 more |
regulation of protein localization to plasma membrane
GO · q=3.57e-4
|
| Cluster 335 | 6 | Bone marrow diseases, Cerebellar diseases, dyskeratosis congenita, autosomal dominant 3, Mowat-wilson syndrome, Revesz debuse syndrome and 1 more |
hindbrain development
GO · q=1.80e-3
|
| Cluster 336 | 6 | Brain anomalies ectodermal dysplasia skeletal malformations hirschsprung disease syndrome, Bresek syndrome, Congenital palmoplantar and perioral keratoderma of olmsted, ifap syndrome 1, with or without bresheck syndrome, Keratosis follicularis spinulosa decalvans, x-linked and 1 more |
negative regulation of hair cycle
GO · q=5.39e-3
|
| Cluster 337 | 6 | Brown tendon sheath syndrome, Hyperparathyroidism, Osteolysis, hereditary, of carpal bones with or without nephropathy, Parathyroid disease, TUBB4A-related neurologic disorder and 1 more |
Parathyroid hormone synthesis, secretion and action
Pathway · q=3.19e-6
|
| Cluster 338 | 6 | Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome due to tab2 mutation, Chromosome 6q24-q25 deletion syndrome, congenital heart defects, multiple types, 2, hereditary spastic paraplegia 8, Ritscher-schinzler syndrome and 1 more |
Golgi to plasma membrane transport
GO · q=1.24e-3
|
| Cluster 339 | 6 | Caudate atrophy, Cerebral cortical atrophy, Nasu-hakola disease, Paraplegia, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy and 1 more |
DNA-templated transcription termination
GO · q=1.17e-5
|
| Cluster 340 | 6 | Caveolinopathy, Chromosome 3p25 monosomy, Creatine phosphokinase elevation, DPAGT1-congenital disorder of glycosylation, Rippling muscle disease and 1 more |
regulation of calcium ion transport
GO · q=1.98e-5
|
| Cluster 341 | 6 | Immunodeficiency-centromeric instability-facial anomalies syndrome, immunodeficiency-centromeric instability-facial anomalies syndrome 1, immunodeficiency-centromeric instability-facial anomalies syndrome 2, immunodeficiency-centromeric instability-facial anomalies syndrome 3, immunodeficiency-centromeric instability-facial anomalies syndrome 4 and 1 more |
chromatin organization
GO · q=1.75e-5
|
| Cluster 342 | 6 | Childhood-onset sensorineural hearing impairment, Hydrops with lactic acidosis and sideroblastic anemia, Perrault syndrome, perrault syndrome 2, Progressive arterial occlusive disease with hypertension and 1 more |
mitochondrial translation
GO · q=6.65e-5
|
| Cluster 343 | 6 | developmental and epileptic encephalopathy, 80, Hyperphosphatasia with intellectual disability syndrome, hyperphosphatasia with intellectual disability syndrome 1, hyperphosphatasia with intellectual disability syndrome 4, hyperphosphatasia with intellectual disability syndrome 6 and 1 more |
GPI anchor biosynthetic process
GO · q=4.89e-20
|
| Cluster 344 | 6 | IL21-related infantile inflammatory bowel disease, Multiple epiphyseal dysplasia with early-onset diabetes mellitus, Progressive supranuclear palsy, Sialolithiasis, TRAF3 haploinsufficiency and 1 more |
negative regulation of mitochondrial fission
GO · q=2.22e-3
|
| Cluster 345 | 6 | Intestinal hypomagnesemia, Magnesium metabolism disorder, Primary hypomagnesemia with hypocalciuria, renal hypomagnesemia 2, renal hypomagnesemia 3 and 1 more |
magnesium ion transmembrane transport
GO · q=2.04e-6
|
| Cluster 346 | 5 | Dna ligase iv deficiency, Dubowitz syndrome, Intellectual developmental disorder short stature behavioral, Lig4 syndrome, Spondylosis |
immunoglobulin V(D)J recombination
GO · q=1.62e-3
|
| Cluster 347 | 5 | Benign epithelial tumor of salivary glands, Liposarcoma, melanoma, cutaneous malignant, susceptibility to, 3, silver-russell syndrome 5, Well-differentiated liposarcoma |
vascular associated smooth muscle cell migration
GO · q=5.63e-5
|
| Cluster 348 | 5 | 15q24 microdeletion, Chromosome 15q24 deletion syndrome, Congenital diaphragmatic hernia, SIN3A-related intellectual disability syndrome, Witteveen-kolk syndrome |
anatomical structure morphogenesis
GO · q=3.60e-6
|
| Cluster 349 | 5 | 17 alpha-hydroxyprogesterone aldolase deficiency, 17-beta-hydroxysteroid dehydrogenase deficiency, 46,xy disorder of sex developmen, Disorders of sex development, Male pseudohypopituitarism |
progesterone metabolic process
GO · q=1.05e-11
|
| Cluster 350 | 5 | 17,20-lyase deficiency, Amenorrhea, Congenital adrenal hyperplasia, Isolated follicle-stimulating hormone deficiency, Steroid 17-alpha-monooxygenase deficiency |
Cortisol synthesis and secretion
Pathway · q=4.98e-11
|
| Cluster 351 | 5 | 17p11.2 microduplication syndrome, Birt-hogg-dube syndrome, Potocki-lupski syndrome, Smith-magenis syndrome, syndromic X-linked intellectual disability Snyder type |
negative regulation of cell proliferation involved in kidney development
GO · q=6.32e-3
|
| Cluster 352 | 5 | 17q21.31 microdeletion syndrome, Dysgenesis of corpus callosum, Juvenile myoclonic epilepsy, koolen-de vries syndrome, multiple congenital anomalies-neurodevelopmental syndrome, x-linked |
regulation of membrane repolarization during atrial cardiac muscle cell action potential
GO · q=5.39e-3
|
| Cluster 353 | 5 | Ataxia telangiectasia, ATM-related cancer predisposition, Chromosome 17q21.31 deletion syndrome, Conjunctival telangiectasis, Intracranial germ cell tumor |
positive regulation of protein-containing complex assembly
GO · q=3.37e-6
|
| Cluster 354 | 5 | 1p36 deletion syndrome, Dyssegmental dysplasia, radio-tartaglia syndrome, Schwartz-jampel syndrome, Silverman-Handmaker type dyssegmental dysplasia |
neural fold bending
GO · q=1.34e-2
|
| Cluster 355 | 5 | 2-methylbutyryl-coa dehydrogenase deficiency, Acral peeling skin syndrome, Brunet-wagner neurodevelopmental syndrome, Peeling skin syndrome, Rheumatic disease |
intrinsic apoptotic signaling pathway by p53 class mediator
GO · q=7.65e-3
|
| Cluster 356 | 5 | 3mc syndrome, Carnevale syndrome, Craniofacial ulnar renal syndrome, Malpuech facial clefting syndrome, Oculopalatosekeletal syndrome |
Lectin pathway of complement activation
Pathway · q=9.10e-7
|
| Cluster 357 | 5 | Carbohydrate metabolism disease, Carbohydrate metabolism disorder, MPI-congenital disorder of glycosylation, Transaldolase deficiency, Triose phosphate isomerase deficiency |
Carbon metabolism
Pathway · q=1.42e-6
|
| Cluster 358 | 5 | holoprosencephaly 3, Partial agenesis of corpus callosum, Preaxial polydactyly with upper back hypertrichosis, Skeletal system disorder, Triphalangeal thumb-polysyndactyly syndrome |
embryonic digit morphogenesis
GO · q=1.96e-3
|
| Cluster 359 | 5 | Acid-base disorder, Amed syndrome, Blepharitis, Respiratory system neoplasm, Wernicke-korsakoff syndrome |
Ethanol oxidation
Pathway · q=4.42e-6
|
| Cluster 360 | 5 | amyotrophic lateral sclerosis type 9, Bosch-boonstra-schaaf optic atrophy syndrome, Cataract-growth hormone deficiency-skeletal dysplasia syndrome, immunodeficiency, common variable, 5, Ovarian cysts |
proteoglycan metabolic process
GO · q=4.89e-3
|
| Cluster 361 | 5 | Cadasil, Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1, inherited thrombocytopenia, Myofibromatosis |
DNA damage checkpoint signaling
GO · q=4.62e-3
|
| Cluster 362 | 5 | Activated pi3k-delta syndrome, Combined immunodeficiency with facio-oculo-skeletal anomalies, immunodeficiency 14, immunodeficiency 14b, autosomal recessive, Roifman syndrome |
Synthesis of PIPs at the plasma membrane
Pathway · q=3.64e-5
|
| Cluster 363 | 5 | agammaglobulinemia 7, autosomal recessive, Diffuse idiopathic skeletal hyperostosis, immunodeficiency 122, PIK3R1-related immunodeficiency and SHORT syndrome, Short syndrome |
transcription by RNA polymerase II
GO · q=8.53e-3
|
| Cluster 364 | 5 | Agat deficiency, Arginine-glycine amidinotransferase deficiency, De toni-debre-fanconi syndrome, Fanconi renotubular syndrome, Fanconi syndrome |
indole metabolic process
GO · q=7.18e-3
|
| Cluster 365 | 5 | Cerebral creatine deficiency syndrome, Creatine deficiency, Creatine transporter deficiency, Guanidinoacetate methyltransferase deficiency, X-linked creatine transporter deficiency |
creatine metabolic process
GO · q=1.49e-9
|
| Cluster 366 | 5 | atypical hemolytic-uremic syndrome with B factor anomaly, C3 glomerulonephritis, Hemolytic uremic syndrome, hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature, Mesangiocapillary glomerulonephritis |
complement activation
GO · q=2.80e-17
|
| Cluster 367 | 5 | Agnathia-otocephaly, Dysgnathia complex, Mak-related retinopathy, Otosclerosis, Retrognathia |
positive regulation of bone resorption
GO · q=4.69e-4
|
| Cluster 368 | 5 | Axial spondylometaphyseal dysplasia, Combined immunodeficiency with autoimmunity and spondylometaphyseal dysplasia, glomerulopathy with fibronectin deposits 2, Spondylometaphyseal dysplasia, spondylometaphyseal dysplasia, 'corner fracture' type |
cartilage development involved in endochondral bone morphogenesis
GO · q=8.64e-4
|
| Cluster 369 | 5 | IFIH1-related type 1 interferonopathy, joubert syndrome 3, Microscopic colitis, Selective iga deficiency disease, Selective immunoglobulin a deficiency |
Allograft rejection
Pathway · q=1.33e-4
|
| Cluster 370 | 5 | Canavan disease, Fraser syndrome, Genetic infertility, Olmsted syndrome, primary ciliary dyskinesia 20 |
mammary gland duct morphogenesis
GO · q=1.46e-3
|
| Cluster 371 | 5 | Aldosterone-producing adenoma, Brain compression, Breast cyst, Primary hyperaldosteronism-seizures-neurological abnormalities syndrome, sinoatrial node dysfunction and deafness |
regulation of heart rate by cardiac conduction
GO · q=3.14e-4
|
| Cluster 372 | 5 | Alopecia-intellectual disability syndrome, Amr syndrome, Cataract-alopecia-sclerodactyly syndrome, Palmoplantar keratoderma and congenital alopecia, Perniola krajewska carnevale syndrome |
triterpenoid biosynthetic process
GO · q=4.40e-3
|
| Cluster 373 | 5 | Atrial septal defect, Bafopathy, Congenital heart septal defect, renpenning syndrome, Ventricular septal defect |
heart development
GO · q=2.15e-13
|
| Cluster 374 | 5 | Amelocerebrohypohidrotic syndrome, Continuous spike and wave during sleep syndrome, Continuous spike and wave during slow wave sleep syndrome, Focal epilepsy with speech disorder and impaired intellectual development, Pyridoxine dependent epilepsy |
memory
GO · q=5.86e-4
|
| Cluster 375 | 5 | Amelogenesis imperfecta, Dentin dysplasia, Dentinogenesis imperfecta, Enamel-renal syndrome, Hypomaturation amelogenesis imperfecta |
biomineral tissue development
GO · q=1.02e-17
|
| Cluster 376 | 5 | autoimmune lymphoproliferative syndrome type 1, Diabetic angiopathies, Diabetic peripheral angiopathy, Dihydropteridine reductase deficiency, Liver failure |
response to hypoxia
GO · q=2.69e-8
|
| Cluster 377 | 5 | Cardiomyopathy, cardiomyopathy, dilated, 2h, Dilated cardiomyopathy, dilated cardiomyopathy 1M, Hypertrophic cardiomyopathy |
Cytoskeleton in muscle cells
Pathway · q=8.32e-32
|
| Cluster 378 | 5 | Calcinosis, Heart valve disease, Heart valve prolapse, Hereditary arterial and articular multiple calcification syndrome, Vitamin k deficiency |
Interleukin-4 and Interleukin-13 signaling
Pathway · q=6.44e-15
|
| Cluster 379 | 5 | Anterior compartment syndrome, Heme oxygenase deficiency, Hemolysis, Intracranial vasospasm, Vascular system injury |
vasodilation
GO · q=3.47e-7
|
| Cluster 380 | 5 | Analbuminemia, Anuria, Blood protein disorder, Congenital analbuminemia, Dysalbuminemic hyperthyroxinemia |
positive regulation of epidermal growth factor receptor signaling pathway
GO · q=4.69e-4
|
| Cluster 381 | 5 | Cerebroretinal microangiopathy with calcifications and cysts, Coats plus syndrome, Congenital chromosomal disease, spermatogenic failure 18, Tumor predisposition syndrome |
telomere capping
GO · q=2.67e-6
|
| Cluster 382 | 5 | Brachydactyly-short stature-retinits pigmentosa syndrome, Diverticulitis, Metaphyseal chondrodysplasia with retinitis pigmentosa, Osteonecrosis, Retinitis pigmentosa with or without skeletal anomalies |
synaptic membrane adhesion
GO · q=2.12e-4
|
| Cluster 383 | 5 | autosomal dominant polycystic kidney disease, IFT140-related recessive ciliopathy, Mainzer-saldino disease, renal-hepatic-pancreatic dysplasia 2, Saldino-mainzer syndrome |
determination of left/right symmetry
GO · q=9.16e-8
|
| Cluster 384 | 5 | Bile duct disease, Bronchopneumonia, Creutzfeldt-jakob disease, Erythropoietic protoporphyria, SRD5A3-congenital disorder of glycosylation |
ERBB2-EGFR signaling pathway
GO · q=3.38e-5
|
| Cluster 385 | 5 | Brittle cornea syndrome, Congenital anomaly of limb, Congenital skin anomaly, geroderma osteodysplastica, Skin abnormalities |
skeletal system development
GO · q=2.53e-9
|
| Cluster 386 | 5 | Aplasia and myelodysplasia, Bone marrow failure syndromes, Congenital bone marrow failure syndrome, Congenital progressive bone marrow failure-b-cell immunodeficiency-skeletal dysplasia syndrome, Growth hormone insensitivity syndrome with immune dysregulation |
regulation of cell population proliferation
GO · q=4.75e-6
|
| Cluster 387 | 5 | Apnea, Butyrylcholinesterase deficiency, Paralysis, Paresis, Trismus |
serotonin metabolic process
GO · q=1.14e-3
|
| Cluster 388 | 5 | Hereditary hyperekplexia, Hyperekplexia, Hyperexplexia hereditary, Retinitis pigmentosa, juvenile cataract, short stature, intellectual disability syndrome, sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
synaptic transmission, glycinergic
GO · q=6.34e-9
|
| Cluster 389 | 5 | Apraxia, Cataplexy, Developmental delay with variable intellectual disability, Marinesco-sjogren syndrome, Ophthalmoplegia |
negative regulation of neuron remodeling
GO · q=1.28e-2
|
| Cluster 390 | 5 | Arachnodactyly, Byzanthine arch palate, Ck syndrome, Congenital hemidysplasia with ichthyosiform erythroderma and limb defects, Perisylvian polymicrogyria |
post-embryonic eye morphogenesis
GO · q=1.66e-4
|
| Cluster 391 | 5 | Asthma, Eczema, Inflammatory skin disease, Intellectual developmental disorder neuropsychiatric, Respiratory system disease |
Inflammatory bowel disease
Pathway · q=9.55e-30
|
| Cluster 392 | 5 | C1 esterase inhibitor deficiency, C9 deficiency, Complement component deficiency, Hereditary c1 esterase inhibitor deficiency, Terminal complement component deficiency |
complement activation
GO · q=8.59e-40
|
| Cluster 393 | 5 | Atypical multiple mole melanoma syndrome, Brain stem neoplasms, Intellectual developmental disorder growth other organ, melanoma-pancreatic cancer syndrome, Trisomy |
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
Pathway · q=2.29e-9
|
| Cluster 394 | 5 | Au-kline syndrome, Chuvash erythrocytosis, Erythrocytosis due to tissue hypoxemia, neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome, Von hippel-lindau syndrome |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
GO · q=7.18e-3
|
| Cluster 395 | 5 | Catel-manzke syndrome, Congenital vertebral-cardiac-renal anomalies syndrome, Hyperopia, Trichotillomania, Vertebral, cardiac, renal, and limb defects syndrome |
regulation of neuronal synaptic plasticity
GO · q=3.07e-4
|
| Cluster 396 | 5 | Autoinflammation, antibody deficiency, and immune dysregulation, Charcot-Marie-Tooth disease type 2T, Cold autoinflammatory syndrome, Congenital membranous nephropathy, Cryopyrin-associated periodic syndrome |
positive regulation of interleukin-1 beta production
GO · q=1.14e-4
|
| Cluster 397 | 5 | Biliary atresia, Central hypoventilation syndrome, Congenital central hypoventilation syndrome, Haddad syndrome, Hirschsprung disease |
neural crest cell migration
GO · q=7.31e-13
|
| Cluster 398 | 5 | Cerebral sinovenous thrombosis, Congenital factor ii deficiency, Congenital prothrombin deficiency, Hemophilia b, thrombophilia due to thrombin defect |
hemostasis
GO · q=1.98e-8
|
| Cluster 399 | 5 | Basal ganglia disease, Fahr's disease, Idiopathic basal ganglia calcification, Primary familial brain calcification, Striatal neurodegeneration |
negative regulation of synaptic transmission, glutamatergic
GO · q=1.48e-5
|
| Cluster 400 | 5 | Beta-propeller protein-associated neurodegeneration, familial hemiplegic migraine, Hemiplegic migraine, X-linked cerebral cerebellar coloboma syndrome, X-linked optic atrophy |
neuronal action potential propagation
GO · q=2.11e-4
|
| Cluster 401 | 5 | Carotid artery thrombosis, Glanzmann thrombasthenia, platelet-type bleeding disorder 16, platelet-type bleeding disorder 18, Thrombasthenia |
blood coagulation
GO · q=7.40e-8
|
| Cluster 402 | 5 | Combined oxidative phosphorylation defect, Dopamine transporter deficiency syndrome, Mild cognitive impairment, Parkinsonism-dystonia, SLC6A3-related dopamine transporter deficiency syndrome |
monoamine transport
GO · q=2.08e-4
|
| Cluster 403 | 5 | Bethlem myopathy, collagen 6-related myopathy, Collagen vi muscular dystrophy, dystonia 27, Ullrich congenital muscular dystrophy |
Collagen chain trimerization
Pathway · q=2.31e-7
|
| Cluster 404 | 5 | Bifunctional enzyme deficiency, Carnitine palmitoyltransferase deficiency, D-bifunctional protein deficiency, Fatty acid metabolism disorder, Peroxisomal disorder |
fatty acid beta-oxidation
GO · q=4.06e-9
|
| Cluster 405 | 5 | immunodeficiency due to CD25 deficiency, Interleukin 2 receptor deficiency, Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidney syndrome, Periprosthetic osteolysis |
regulation of T cell tolerance induction
GO · q=1.22e-2
|
| Cluster 406 | 5 | Bladder neck obstruction, Carcinoma in situ, Ovarian diseases, Pericardial effusion, Urinary bladder neck obstruction |
Ovarian steroidogenesis
Pathway · q=1.13e-4
|
| Cluster 407 | 5 | Hypocalcemic vitamin d-dependent rickets, Pancreatic trypsinogen deficiency, Peptic esophagitis, Rickets, Vitamin d dependent rickets |
calcitriol biosynthetic process from calciol
GO · q=3.16e-7
|
| Cluster 408 | 5 | COG4-congenital disorder of glycosylation, Expressive language delay, Gross motor development delay, microcephalic osteodysplastic dysplasia, Saul-Wilson type, Saul-wilson syndrome |
muscle contraction
GO · q=9.46e-5
|
| Cluster 409 | 5 | Borjeson-forssman-lehmann syndrome, Cerebrofaciothoracic dysplasia, Congenital fusion of ribs, Congenital hypoplasia of penis, Craniofacial dysmorphism skeletal anomalies intellectual disability syndrome |
multi-pass transmembrane protein insertion into ER membrane
GO · q=1.50e-4
|
| Cluster 410 | 5 | C syndrome, Corneal ulcer, Eye disease, Proliferative diabetic retinopathy, retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome |
vitamin A metabolic process
GO · q=5.62e-4
|
| Cluster 411 | 5 | Chagas cardiomyopathy, Chudley-mccullough syndrome, Hereditary elliptocytosis, Neonatal anemia, Perinatal hemolytic anemia |
actin filament capping
GO · q=2.94e-4
|
| Cluster 412 | 5 | Cortical dysplasia-focal epilepsy syndrome, Dyslexia, holocarboxylase synthetase deficiency, Male infertility acephalic spermatozoa, Specific language disorder |
vocal learning
GO · q=1.41e-5
|
| Cluster 413 | 5 | Breast neoplasms , Coloboma, cleft lip-palate and mental retardation syndrome, Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development, Uveal coloboma-cleft lip and palate-intellectual disability, Zunich neuroectodermal syndrome |
regulation of G2/M transition of mitotic cell cycle
GO · q=2.94e-5
|
| Cluster 414 | 5 | Bullous diffuse cutaneous mastocytosis, Mast cell leukemia, Telangiectasia macularis eruptiva perstans, Testicular seminoma, Urticaria pigmentosa |
melanocyte adhesion
GO · q=1.93e-3
|
| Cluster 415 | 5 | Carasil syndrome, Malignant peripheral nerve sheath tumor, Malignant triton tumor, Small vessel stroke, spinocerebellar ataxia, autosomal recessive 31 |
Inflammatory mediator regulation of TRP channels
Pathway · q=1.12e-2
|
| Cluster 416 | 5 | Cardiogenetic disease, Congenital esophageal anomaly, Congenital insufficiency of mitral valve, Repolarization syndrome, X-linked opitz syndrome |
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis
GO · q=9.50e-3
|
| Cluster 417 | 5 | Congenital neck anomaly, Deglutition disorder, Distal nebulin myopathy, Nebulin-related myopathy, nemaline myopathy 2 |
tRNA-type intron splice site recognition and cleavage
GO · q=4.13e-8
|
| Cluster 418 | 5 | Cerebellar atrophy with seizures and variable developmental delay, complex neurodevelopmental disorder with motor features, generalized epilepsy-paroxysmal dyskinesia syndrome, Gingival diseases, Prostatic hyperplasia |
response to follicle-stimulating hormone
GO · q=4.10e-4
|
| Cluster 419 | 5 | Cerebral saccular aneurysm, Connective and soft tissue disorder, ehlers-danlos syndrome, vascular type, Nephrosclerosis, Vascular ehlers-danlos syndrome |
positive regulation of vasculature development
GO · q=1.29e-6
|
| Cluster 420 | 5 | Cleft palate psychomotor retardation distinctive facial features, Macronodular adrenal hyperplasia, Osteoma cutis, palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome, Primary bilateral macronodular adrenal hyperplasia |
positive regulation of cold-induced thermogenesis
GO · q=2.82e-3
|
| Cluster 421 | 5 | Colorectal cancer susceptibility, mandibular hypoplasia-deafness-progeroid syndrome, non-severe combined immunodeficiency due to polymerase delta deficiency, Paraquat lung disease, POLD1-related polyposis and colorectal cancer syndrome |
PCNA-Dependent Long Patch Base Excision Repair
Pathway · q=9.92e-6
|
| Cluster 422 | 5 | Congenital folate absorption defect, Hereditary folate malabsorption, Malabsorption syndrome, MECOM-associated syndrome, Pancytopenia |
tetrahydrofolate biosynthetic process
GO · q=6.33e-4
|
| Cluster 423 | 5 | Congenital cataract hypertrophic cardiomyopathy mitochondrial myopathy syndrome, mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Sengers syndrome, Trichohepatoenteric syndrome, Triokinase and fmn cyclase deficiency |
apoptotic mitochondrial changes
GO · q=1.00e-3
|
| Cluster 424 | 5 | Glycosylphosphatidylinositol biosynthesis defect, glycosylphosphatidylinositol biosynthesis defect 15, glycosylphosphatidylinositol biosynthesis defect 17, glycosylphosphatidylinositol biosynthesis defect 18, glycosylphosphatidylinositol biosynthesis defect 21 |
GPI anchor biosynthetic process
GO · q=1.42e-14
|
| Cluster 425 | 5 | Digestive system neoplasms, Dysferlinopathy, Genetic recurrent myoglobinuria, H syndrome, myoglobinuria, acute recurrent, autosomal recessive |
monoatomic anion transmembrane transport
GO · q=4.37e-3
|
| Cluster 426 | 5 | Reducing body myopathy, Uruguay faciocardio-musculoskeletal syndrome, X-linked emery-dreifuss muscular dystrophy, X-linked myopathy, X-linked scapuloperoneal muscular dystrophy |
muscle organ development
GO · q=3.32e-3
|
No clusters match these filters.
426 clusters, largest first by default. Click a column header to re-sort, or use the search box above to jump straight to a specific disease's cluster.